Accessibility Helper DemoAdvertisers
ToolTip PluginAdvertisers
Form StylesAdvertisers
  • Printer Friendly Version
  • Decrease Text Size Increase Text Size

Icons: Print, Email, Share, Text Size (Top right all pages)Zones  Icons: Print, Email, Share, Text Size serveBanners
*<b>Important This ad serves Breadcrumb Trail | Icons | Mobile Menu atop page</b>Advertisers
Page Meta DataData Sources

*Word Plug In with SmartLink

Centralpoint
Welcome, Log In
Modules
Taxonomy Filter
Sample Record
05/14/2026 GenericEnhancedA
I like lasagne, and my favorite band is The Beatles
view
Weight Loss Educational Guideline 109a (29724)
05/07/2026 GenericEnhancedA
GDC64 Tablet Aircraft Interface Unit (TAIU) •     Appr     F •     Pr • • even mor • the iPad.     W air •                                                                                                                                                                                                        DAC International 6702 McNeil Drive, Austin, Texas 78729 P. 800.527.2531 (U.S. only) | 512.331.5323 F: 512.331.4516 dacinfo@dacint.com | www.dacint.com Typical features of GDC64: &...
view
Controlled Substances Narcotics _ Opioids Scheduled Drugs MEDS 027 (29980) (1)
05/07/2026 GenericEnhancedA
GDC64 Tablet Aircraft Interface Unit (TAIU) •     Appr     F •     Pr • • even mor • the iPad.     W air •                                                                                                                                                                                                        DAC International 6702 McNeil Drive, Austin, Texas 78729 P. 800.527.2531 (U.S. only) | 512.331.5323 F: 512.331.4516 dacinfo@dacint.com | www.dacint.com Typical features of GDC64: &...
view
Gartner Hype Cycle
05/06/2026 GenericEnhancedA
Market Trends: Unification of the User Experience Platform Marketplace Published: 31 March 2016 Analyst(s): Fabrizio Biscotti, Gene Phifer The user experience platform is key to acquire and retain new customers, and strategic planners should provide guidance to help customers move from a purely technology-led to a strategically business-driven implementation of the UXP. Key Findings ■ Enterprises now see the user experience platform (UXP) as critical to their success, and commitment to the UXP extends beyond IT departments to be of primary concern for CMOs' communication and brand management strategies. ■ As UXP products become more popular and attractive for businesses, during the next five years, we will continue to see the market for UXP suites slowly absorbing some of the stand- alone offerings. ■ Total software revenue of all UXP ecosystem components is presently estimated at about $32 billion, of which about $3.0 billion is for holistic UXPs. ■ Demand is coming from not only well-established corporations with large budgets, but also smaller organizations. Recommendations Vendor strategic planners should: ■ Target the key buyers as the buying centers are changing, and be ready to talk to the marketing and line-of-business people within an enterprise rather than to CTOs and CIOs. ■ Take a vertical market approach as several industries are seeing the greatest benefit from purchasing UXPs and will be very active in this space. Pay particular attention to financial servic...
view
Sample
05/05/2026 GenericEnhancedA
Market Trends: Unification of the User Experience Platform Marketplace Published: 31 March 2016 Analyst(s): Fabrizio Biscotti, Gene Phifer The user experience platform is key to acquire and retain new customers, and strategic planners should provide guidance to help customers move from a purely technology-led to a strategically business-driven implementation of the UXP. Key Findings ■ Enterprises now see the user experience platform (UXP) as critical to their success, and commitment to the UXP extends beyond IT departments to be of primary concern for CMOs' communication and brand management strategies. ■ As UXP products become more popular and attractive for businesses, during the next five years, we will continue to see the market for UXP suites slowly absorbing some of the stand- alone offerings. ■ Total software revenue of all UXP ecosystem components is presently estimated at about $32 billion, of which about $3.0 billion is for holistic UXPs. ■ Demand is coming from not only well-established corporations with large budgets, but also smaller organizations. Recommendations Vendor strategic planners should: ■ Target the key buyers as the buying centers are changing, and be ready to talk to the marketing and line-of-business people within an enterprise rather than to CTOs and CIOs. ■ Take a vertical market approach as several industries are seeing the greatest benefit from purchasing UXPs and will be very active in this space. Pay particular attention to financial servic...
view
Sample
05/05/2026 GenericEnhancedA
fr it de es pl pt hu tr ru nl fr it de es pl pt hu tr ru nl
view
Sample Accessibility Record
05/05/2026 GenericEnhancedA
Cowlitz Fish Technical Committee     2022-03 Decision Document   Project Name SA Article 3: Cowlitz Restoration and Recovery (CRR) Hatchery-Associated Production (HAP) Subcommittee Charter Date Proposal Summited April 5, 2022 Date of Requested Decision 1 May 3, 2022 Requested By Melora Shelton Date of Decision May 10, 2022   1 Decision will become final if committee members who were not present at this meeting do not oppose this proposed decision within 7 days     FTC Decision and Justification   The FTC approves the development of a subcommittee to develop the Hatchery Associated Production (HAP) element of the Cowlitz Restoration Recovery (CRR) program and the FTC approves the charter included in this decision document.   This subcommittee will provide technical expertise in HAP to develop program guidance and ways to evaluate proposals for the HAP element of the CRR program.    FTC members present at 5/3 FTC meeting included - WDFW, Ecology, Trout Unlimited, and Tacoma Power.       Proposed Decision for Consideration   The FTC technical representatives listed below (“Membership”) recommend that the FTC formalize a subcommittee to advise on hatchery-associated production (HAP) elements of the CRR program and approve the HAP Subcommittee Charter described herein.   Background   CRR Hatchery-Associated Production (HAP) Subcommittee Charter   Directive:   The Cowlitz Fisheries Technic...
view
Math Formulas
05/05/2026 GenericEnhancedA
PHYS 2310 Engineering Physics I Formula Sheets Chapters 1-18 Chapter 1/Important Numbers Chapter 2 Units for SI Base Quantities Velocity Quantity Unit Name Unit Symbol 𝑑𝑖𝑠𝑝𝑙𝑎𝑐𝑒𝑚𝑒𝑛𝑡 ∆𝑥 Length Meter M Average Velocity 𝑉 = = 2.2 𝑎𝑣𝑔 𝑡𝑖𝑚𝑒 ∆𝑡 Time Second s Mass (not weight) Kilogram kg 𝑡𝑜𝑡𝑎𝑙 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 Average Speed 𝑠𝑎𝑣𝑔 = 2.3 𝑡𝑖𝑚𝑒 ∆𝑥̅ 𝑑𝑥 Common Conversions Instantaneous Velocity 𝑣 = lim = 2.4 1 kg or 1 m 1000 g or m 1 m 1 × 106 𝜇𝑚 ∆𝑡→0 ∆𝑡 𝑑𝑡 1 m 100 cm 1 inch 2.54 cm 1 m 1000 mm 1 day 86400 seconds Acceleration 1 second 1000 milliseconds 1 hour 3600 seconds 1 m 3.281 ft 360° 2𝜋 rad ∆𝑣 Average Acceleration 𝑎 = 2.7 𝑎𝑣𝑔 ∆𝑡 Important Constants/Measurements 𝑑𝑣 𝑑2𝑥 24 Instantaneous 2.8 Mass of Earth 5.98 × 10 kg 𝑎 = = 2 Acceleration 𝑑𝑡 𝑑𝑡 2.9 Radius of Earth 6.38 × 106 m 1 u (Atomic Mass Unit) 1.661 × 10−27 kg Density of water 1 𝑔/𝑐𝑚3 or 1000 𝑘𝑔/𝑚3 Motion of a particle with constant acceleration g (on earth) 9.8 m/s2 𝑣 = 𝑣0 + 𝑎𝑡 2.11 Density 1 ∆𝑥 = (𝑣 + 𝑣)𝑡 2.17 Common geometric Formulas 2 0 2 Circumference 𝐶 = 2𝜋𝑟 Area circle 𝐴 = 𝜋𝑟 1 2 ∆𝑥 = 𝑣0𝑡 + 𝑎𝑡 2.15 Surface area 4 3 2 𝑆𝐴 = 4𝜋𝑟2 Volume (sphere) 𝑉 = 𝜋𝑟 (sphere) 3 2 2 𝑣 = 𝑣0 + 2𝑎∆𝑥 2.16 𝑉 = 𝑙 ∙ 𝑤 ∙ ℎ Volume (rectangular solid) 𝑉 = 𝑎𝑟𝑒𝑎 ∙ 𝑡ℎ𝑖𝑐𝑘𝑛𝑒𝑠𝑠 Chapter 3 Chapter 4 Adding Vectors ⃗⃗ ⃗⃗ 3.2 Position vector 𝑟⃗ = 𝑥𝑖̂ + 𝑦𝑗̂ + 𝑧𝑘̂ 4.4 Geometrically 𝑎⃗ + 𝑏 = 𝑏 + 𝑎⃗ Adding Vectors displacement ∆𝑟⃗ = ∆𝑥𝑖...
view
Sample PDF 2
05/05/2026 GenericEnhancedA
fr it de es pl pt hu tr ru nl fr it de es pl pt hu tr ru nl
view
Sample PDF
05/05/2026 GenericEnhancedA
Market Trends: Unification of the User Experience Platform Marketplace Published: 31 March 2016 Analyst(s): Fabrizio Biscotti, Gene Phifer The user experience platform is key to acquire and retain new customers, and strategic planners should provide guidance to help customers move from a purely technology-led to a strategically business-driven implementation of the UXP. Key Findings ■ Enterprises now see the user experience platform (UXP) as critical to their success, and commitment to the UXP extends beyond IT departments to be of primary concern for CMOs' communication and brand management strategies. ■ As UXP products become more popular and attractive for businesses, during the next five years, we will continue to see the market for UXP suites slowly absorbing some of the stand- alone offerings. ■ Total software revenue of all UXP ecosystem components is presently estimated at about $32 billion, of which about $3.0 billion is for holistic UXPs. ■ Demand is coming from not only well-established corporations with large budgets, but also smaller organizations. Recommendations Vendor strategic planners should: ■ Target the key buyers as the buying centers are changing, and be ready to talk to the marketing and line-of-business people within an enterprise rather than to CTOs and CIOs. ■ Take a vertical market approach as several industries are seeing the greatest benefit from purchasing UXPs and will be very active in this space. Pay particular attention to financial servic...
view
Sample Word Document
05/05/2026 GenericEnhancedA
/* This document contains the TSQL needed to configure Classic Mirroring using certificates for encrypted mirroring connections*/ We will need 2 servers with the same version of SQL Server on Principal and Mirror . We will also create 2 Logins and 2 users.   PRINCIPAL_LOGIN and PRINCIPAL_USER ; MIRROR_LOGIN and MIRROR_USER Based on these logins, we will create a certificate. For testing purposes, we will use a database called mirrordbtest . Please replace this with the user database that you want to mirror.   Note: Before starting, please take a full and log backup from Principal to restore on Mirror with option R ESTORE WITH NORECOVERY . https://docs.microsoft.com/en-us/sql/database-engine/database-mirroring/prepare-a-mirror-database-for-mirroring-sql-server?view=sql-server-ver15#CombinedProcedure   Create a directory to store the certificates on each server.   In this example script below, we used C:\Certs to simplify the script across all servers. All 2 certificates will be stored here. We are using port 5022 for the mirroring endpoint so please open the firewall/Network Security Group for port 5022.*/   --===========================================================-- --===========================================================-- /*Create the master key, certificate from the master key, and encrypt the mirroring endpoint on the Principal * Please use a secure password / --create a master key on Principal USE master;   CREATE MASTER KEY ENC...
view
Key Strategies for Preventing COVID 19
09/16/2025 GenericEnhancedA
          Roadmap: Key Strategies for Preventing COVID-19 in Nursing Homes   What strategies should our facility use to prevent the spread of COVID-19?   All of the following strategies should be used:   #1 Universal Staff Screening Actively monitor all staff daily for fever and symptoms of COVID-19. If any staff screens positive for any fever or symptoms, they should be tested for COVID-19 and sent home to recover. See “When You Have COVID-19 Cases in Your Nursing Home.” Upon entry, obtain staff temperature using a touchless thermometer. In addition, inquire about any of the following: The Orange County Nursing Home Infection Prevention Team is coordinated by the University of California, Irvine Health and is jointly funded by Orange County Health Care Agency and CalOptima Last Updated: 5/26/20     Fever 99.0 Chills New cough New shortness of breath Muscle aches Unexpected fatigue Sore throat Loss of taste or smell Headache Diarrhea Vomiting Nausea Other cold symptoms       #2 Universal Resident Screening Actively monitor all residents daily for fever and symptoms of COVID-19, as above. If any of these symptoms are found, the resident should be isolated from other residents and a physician should assess the resident for additional medical care needs. See “When You Have COVID-19 Cases in Your Nursing Home” .   #3 Universal Masking Staff should all wear a mask covering the nose and mouth whenever on nurs...
view
OOXML Test
04/29/2026 GenericEnhancedA
    Project Name 2026 TWG Evaluation Recommendations Date Proposal Submitted January 6, 2026 Date of Requested Decision March 6, 2026 Completed By Jenise Bauman Date of Decision 1 March 6, 2026   1 Decision will become final if committee members who were not present at this meeting do not oppose this proposed decision within 7 days.   FTC Decision and Justification The TWG subcommittee seeks approval from the FTC in implementing the five actions proposed by Tacoma Power, supported by the Technical Working Group (TWG), and described herein as part of the 2026 evaluation year at the Cowlitz Falls North Shore Collector and Mayfield Juvenile Collection Facility. The FTC approved implementing these actions. FTC members present included: WDFW (Bryce Glaser), Ecology (Andrew Luymes), Trout Unlimited (Jonathan Stumpf), and Tacoma Power (Melora Shelton).   Proposed Decision or Consideration As part of the 2026 evaluation year at the Cowlitz Falls North Shore Collector (CFNSC) and Mayfield Juvenile Collection Facility, Tacoma proposes implementing three actions intended to inform management decisions and/or test hypotheses regarding salmon and steelhead collection efficiency and survival: Alternate Tagging Strategy: This alternative tagging strategy is designed to improve estimates of fish collection efficiency (FCE) of steelhead, coho, and Chinook. The alternative tagging strategy covers more of the collection season for each species. It also provides more...
view
Sample
04/29/2026 GenericEnhancedA
Market Trends: Unification of the User Experience Platform Marketplace Published: 31 March 2016 Analyst(s): Fabrizio Biscotti, Gene Phifer The user experience platform is key to acquire and retain new customers, and strategic planners should provide guidance to help customers move from a purely technology-led to a strategically business-driven implementation of the UXP. Key Findings ■ Enterprises now see the user experience platform (UXP) as critical to their success, and commitment to the UXP extends beyond IT departments to be of primary concern for CMOs' communication and brand management strategies. ■ As UXP products become more popular and attractive for businesses, during the next five years, we will continue to see the market for UXP suites slowly absorbing some of the stand- alone offerings. ■ Total software revenue of all UXP ecosystem components is presently estimated at about $32 billion, of which about $3.0 billion is for holistic UXPs. ■ Demand is coming from not only well-established corporations with large budgets, but also smaller organizations. Recommendations Vendor strategic planners should: ■ Target the key buyers as the buying centers are changing, and be ready to talk to the marketing and line-of-business people within an enterprise rather than to CTOs and CIOs. ■ Take a vertical market approach as several industries are seeing the greatest benefit from purchasing UXPs and will be very active in this space. Pay particular attention to financial servic...
view
warranty-policy-07-18A
01/20/2026 GenericEnhancedA
6390RoseLane,Carpinteria,CA93013USA TEL:+1 -805-684-8307TollFree(USA): 888-373-3027 FAX:+1 -805-566-2196 EMAIL: info@dac-intl.com Website: www.dac-intl.com WARRANTYANDCLAIMS Warranty ForequipmentandmaterialmanufacturedbytheSeller,theSellerwarrantssuchequipmentfora periodofone(1)yearfromdateofinstallationunder normaluseandserviceagainstimproper performancecausedbydefectivematerialsorworkmanship.Thiswarrantyiseffectiveforone(1)year regardlessofthenumberofhoursperdayofequipmentuse. TheSellerwill,onrequestoftheBuyer,providetotheBuyeraserviceengineertorepairorreplace faultypartsormakenecessaryadjustmentsorcalibrations,providedthattheBuyerisunabletomake necessaryrepairswithpartsandinstructionsfurnishedbytheSellerandfurther,hasfollowedthe maintenanceandcheck-outinstructionsandproperlycompletedperiodicwarrantyinspectionsif detailedbythemachineoperatingmanual.TherewillbenochargetotheBuyerforpartsandlabor.The Buyerwillberesponsibleforpaymentofalltravelexpensesoftheserviceengineer,includingbutnot limitedtoairfare,localtransportation(taxis,trains,buses,etc.),hotels,parking,rentalcar,mileage,and food. AnywarrantycostbornebyDACInternationalasaresultofimproperinstallationbytheuser(power notbeingwithinDACInternationalproductspecifications,orcausedbyotherinstallationfault)shallbe billablebyDACInternationaltotheuseratstandardfieldservicerates. ExceptasexpresslywarrantedintheSalesOrder,theSellermakesnootherwarrantyofanykind, expressedorimplied,includinganywarrantycoveringordinarywearandtear...
view
Triangular co-operation factsheet Sept 2016
01/20/2026 GenericEnhancedA
DAC GLOBAL RELATIONS TRIANGULAR CO-OPERATION – Findings from a 2015 Survey* A total of 73 actors from government and international organisations responded to a survey on triangular co‑operation conducted by the OECD between May and August 2015 (from the 203 questionnaires sent out). Detailed information was obtained on over 400 triangular co‑operation programmes, projects and activities from 60 respondents. The report “Dispelling the myths of triangular co‑operation ‑ Evidence from the 2015 OECD survey on triangular co‑operation” provides a detailed description and analysis of the survey findings, which are summarised in this factsheet. Who are the actors involved in Triangular Co-operation? According to the survey findings, the main actors in triangular co‑operation are governments or international organisations (61% of the reported projects). In addition, academia and research institutions (14%), civil society organisations, media and foundations (13%), the private sector (6%), and other actors (5%, e.g. hospitals, wildlife authorities, cities) provide valuable inputs. Actors involved in triangular projects can be facilitators, pivotal partners and beneficiaries, as concluded at the Policy Dialogue on Triangular Co‑operation held in Lisbon in May 2013 (www.oecd.org/dac/dac-global- relations/dialogue-triangular-cooperation.htm). These roles can evolve over time. Based on the 60 responses received, the most active countries in triangular co‑operation were Japan, Chile, Brazil...
view
privacy-policy
01/20/2026 GenericEnhancedA
DAC International Privacy Policy Internet Usage Access to the Internet has been provided to certain employees for the benefit of the Company and its customers. It allows employees to connect to information resources around the world. Employees are responsible for ensuring that the Internet is used in an effective, ethical and lawful manner. All communication should be for professional reasons. Employees are not to participate in chat groups/rooms concerning the Company or its business unless their job specifically requires that they do so. All information created, sent or retrieved over the Internet is the property of the Company. Employees should be aware that once information is placed on the Internet, such information might become generally available to the public. The Company reserves the right to access and monitor all messages and files on the computer system as deemed necessary and appropriate. No employee should have any expectation of privacy as to his or her Internet usage. To prevent computer viruses from being transmitted through the system, there will be no unauthorized downloading of any software. All software downloads will be supervised by the IT Department. Downloaded software must be used only under the terms of its license. Since a wide variety of materials may be deemed offensive by colleagues and customers, it is a violation of Company policy to store, view and print or redistribute such documents or graphic files that are not directly related to the u...
view
DAC-GDC64-flyer-03-17-15
01/20/2026 GenericEnhancedA
GDC64 Tablet Aircraft Interface Unit (TAIU) •     Appr     F •     Pr • • even mor • the iPad.     W air •                                                                                                                                                                                                        DAC International 6702 McNeil Drive, Austin, Texas 78729 P. 800.527.2531 (U.S. only) | 512.331.5323 F: 512.331.4516 dacinfo@dacint.com | www.dacint.com Typical features of GDC64: &...
Force Majeure
02/26/2026 GenericEnhancedY
Force Majeure. Neither Party shall be liable for any failure or delay in performing its obligations under this Agreement where such failure or delay results from any cause that is beyond the reasonable control of that Party, including but not limited to: acts of God, flood, fire, earthquake, volcanic eruption, or other natural disaster; epidemic, pandemic, or public health emergency; war, invasion, act of foreign enemies, hostilities (whether war is declared or not), civil war, rebellion, revolution, insurrection, military or usurped power, or confiscation; terrorist activities, sanctions, embargo, or blockade; strikes, lockouts, or other industrial disputes; governmental orders, laws, regulations, or restrictions; failure of third-party telecommunications or power supply; or any other event beyond the reasonable control of the affected Party. The affected Party shall use all reasonable endeavors to mitigate the effect of the Force Majeure Event on the performance of its obligations. If the period of delay or non-performance continues for a period of ninety (90) consecutive days, the Party not affected may terminate this Agreement by giving thirty (30) days' written notice to the affected Party.
Indemnification
02/26/2026 GenericEnhancedY
Indemnification. Each Party (the "Indemnifying Party") shall indemnify, defend, and hold harmless the other Party, its affiliates, officers, directors, employees, agents, successors, and assigns (collectively, the "Indemnified Party") from and against any and all losses, damages, liabilities, deficiencies, claims, actions, judgments, settlements, interest, awards, penalties, fines, costs, or expenses of whatever kind, including reasonable attorneys' fees, that are incurred by the Indemnified Party arising out of or related to: (a) any breach or non-fulfillment of any representation, warranty, or obligation under this Agreement by the Indemnifying Party; (b) any negligent or wrongful act or omission of the Indemnifying Party or its personnel; or (c) any bodily injury, death of any person, or damage to real or tangible personal property caused by the willful or negligent acts or omissions of the Indemnifying Party. The Indemnified Party shall promptly notify the Indemnifying Party in writing of any claim and shall provide reasonable cooperation in the defense of such claim at the Indemnifying Party's expense.
Limitation of Liability
02/26/2026 GenericEnhancedY
Limitation of Liability. IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER PARTY FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, PUNITIVE, OR EXEMPLARY DAMAGES, INCLUDING BUT NOT LIMITED TO DAMAGES FOR LOSS OF PROFITS, GOODWILL, USE, DATA, OR OTHER INTANGIBLE LOSSES (EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES), ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT. EXCEPT FOR A PARTY'S INDEMNIFICATION OBLIGATIONS, BREACH OF CONFIDENTIALITY, OR WILLFUL MISCONDUCT, EACH PARTY'S TOTAL CUMULATIVE LIABILITY ARISING OUT OF OR RELATED TO THIS AGREEMENT SHALL NOT EXCEED THE AGGREGATE AMOUNT OF FEES PAID OR PAYABLE BY THE RECEIVING PARTY TO THE PROVIDING PARTY DURING THE TWELVE (12) MONTH PERIOD IMMEDIATELY PRECEDING THE EVENT GIVING RISE TO THE CLAIM. THE FOREGOING LIMITATIONS SHALL APPLY NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED HEREIN.
Governing Law & Jurisdiction
02/26/2026 GenericEnhancedY
Governing Law and Jurisdiction. This Agreement and any dispute or claim arising out of or in connection with it or its subject matter or formation (including non-contractual disputes or claims) shall be governed by and construed in accordance with the laws of the State of [State], without regard to its conflict of law provisions. Each Party irrevocably agrees that the federal and state courts located in [County], [State] shall have exclusive jurisdiction to settle any dispute or claim arising out of or in connection with this Agreement. Each Party irrevocably waives any objection which it may have at any time to the laying of venue of any proceedings brought in any such court, waives any claim that such proceedings have been brought in an inconvenient forum, and further waives the right to object, with respect to such proceedings, that such court does not have jurisdiction over such Party.
Confidentiality
02/26/2026 GenericEnhancedY
Confidentiality. Each Party (a "Receiving Party") agrees that all Confidential Information disclosed to it by the other Party (the "Disclosing Party") shall be held in strict confidence and shall not be disclosed to any third party without the prior written consent of the Disclosing Party, except to those employees, contractors, and advisors who have a need to know such information in connection with this Agreement and who are bound by confidentiality obligations no less restrictive than those contained herein. "Confidential Information" means all non-public information disclosed by either Party to the other, whether orally, in writing, or by inspection, that is designated as confidential or that reasonably should be understood to be confidential given the nature of the information and the circumstances of disclosure. Confidential Information shall not include information that: (a) is or becomes publicly available without breach of this Agreement; (b) was known to the Receiving Party prior to disclosure; (c) is received from a third party without restriction on disclosure; or (d) is independently developed without use of the Disclosing Party's Confidential Information. The obligations of confidentiality shall survive the termination of this Agreement for a period of five (5) years.
Termination
02/26/2026 GenericEnhancedY
Termination. Either Party may terminate this Agreement upon sixty (60) days' prior written notice to the other Party. Either Party may terminate this Agreement immediately upon written notice if the other Party: (a) commits a material breach of any provision of this Agreement and fails to cure such breach within thirty (30) days after receipt of written notice specifying the nature of the breach; (b) becomes insolvent, makes an assignment for the benefit of creditors, or becomes the subject of any proceeding under any bankruptcy or insolvency law; or (c) ceases to conduct business in the normal course. Upon termination or expiration of this Agreement: (i) all rights and licenses granted hereunder shall immediately terminate; (ii) each Party shall promptly return or destroy all Confidential Information of the other Party in its possession; (iii) all fees and expenses accrued prior to the effective date of termination shall become immediately due and payable; and (iv) any provisions that by their nature should survive termination shall continue in full force and effect.
Assignment
02/26/2026 GenericEnhancedY
Assignment. Neither Party may assign, transfer, delegate, or otherwise dispose of this Agreement, or any of its rights or obligations hereunder, without the prior written consent of the other Party, which consent shall not be unreasonably withheld, conditioned, or delayed; provided, however, that either Party may assign this Agreement without consent to an affiliate or in connection with a merger, acquisition, corporate reorganization, or sale of all or substantially all of its assets, so long as the assignee assumes all obligations of the assigning Party under this Agreement. Any purported assignment in violation of this provision shall be null and void. Subject to the foregoing restrictions, this Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors and permitted assigns.
Severability
02/26/2026 GenericEnhancedY
Severability. If any provision of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, or unenforceable, the validity, legality, and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. The Parties shall negotiate in good faith to replace any invalid, illegal, or unenforceable provision with a valid, legal, and enforceable provision that has the same or similar effect and intent as the provision being replaced. If the Parties are unable to agree on a replacement provision, the invalid, illegal, or unenforceable provision shall be modified to the minimum extent necessary to make it valid, legal, and enforceable while preserving the Parties' original intent.
Entire Agreement
02/26/2026 GenericEnhancedY
Entire Agreement. This Agreement, together with all exhibits, schedules, and attachments hereto, constitutes the entire agreement between the Parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, representations, warranties, and understandings, whether oral or written, relating to such subject matter. No amendment, modification, or supplement to this Agreement shall be binding unless executed in writing by both Parties. In the event of any conflict between the terms of this Agreement and any exhibit, schedule, or attachment, the terms of this Agreement shall prevail unless the exhibit, schedule, or attachment expressly states that it is intended to supersede a specific provision of this Agreement.
Notices
02/26/2026 GenericEnhancedY
Notices. All notices, requests, demands, and other communications required or permitted under this Agreement shall be in writing and shall be deemed to have been duly given: (a) when delivered personally; (b) when sent by confirmed electronic mail (with a copy sent by first-class mail); (c) three (3) business days after being sent by registered or certified mail, return receipt requested, postage prepaid; or (d) one (1) business day after deposit with a nationally recognized overnight courier service, properly addressed and with all charges prepaid. Notices shall be sent to the addresses set forth on the signature page of this Agreement, or to such other address as either Party may designate by written notice to the other Party in accordance with this provision.
Representations and Warranties
02/26/2026 GenericEnhancedY
Representations and Warranties. Each Party represents and warrants to the other Party that: (a) it is duly organized, validly existing, and in good standing under the laws of its jurisdiction of organization; (b) it has the full right, power, and authority to enter into this Agreement, to perform its obligations hereunder, and to grant the rights and licenses granted herein; (c) the execution, delivery, and performance of this Agreement does not and will not conflict with any agreement, obligation, or instrument to which it is a party or by which it is bound; (d) this Agreement constitutes a legal, valid, and binding obligation enforceable against it in accordance with its terms; and (e) it shall comply with all applicable laws, rules, regulations, and governmental orders in the performance of its obligations under this Agreement.
Dispute Resolution / Arbitration
02/26/2026 GenericEnhancedY
Dispute Resolution. Any dispute, controversy, or claim arising out of or relating to this Agreement, or the breach, termination, or invalidity thereof, shall first be submitted to mediation in accordance with the mediation rules of the American Arbitration Association (AAA). If mediation is unsuccessful, the dispute shall be finally resolved by binding arbitration administered by the AAA in accordance with its Commercial Arbitration Rules. The arbitration shall be conducted by a single arbitrator mutually agreed upon by the Parties, or, if the Parties cannot agree, appointed by the AAA. The seat of arbitration shall be [City, State]. The arbitrator shall have the authority to award any remedy or relief that a court of competent jurisdiction could order, including specific performance of any obligation under this Agreement, the awarding of damages as provided for in this Agreement, and the issuance of an injunction. The decision of the arbitrator shall be final and binding on the Parties and may be entered and enforced in any court of competent jurisdiction. Each Party shall bear its own costs and attorneys' fees, unless the arbitrator determines otherwise.
Waiver
02/26/2026 GenericEnhancedY
Waiver. No waiver by either Party of any breach of this Agreement shall be deemed a waiver of any preceding or subsequent breach. No waiver shall be effective unless made in writing and signed by an authorized representative of the waiving Party. The failure of either Party to enforce any provision of this Agreement shall not be construed as a waiver of such provision or the right to enforce it at a later time. The exercise of any right or remedy provided in this Agreement shall be without prejudice to the right to exercise any other right or remedy provided by law or equity, except as expressly limited by this Agreement.
Survival
02/26/2026 GenericEnhancedY
Survival. The provisions of this Agreement that by their nature are intended to survive termination or expiration of this Agreement shall so survive, including without limitation the provisions relating to confidentiality, indemnification, limitation of liability, intellectual property rights, representations and warranties, governing law, dispute resolution, and any payment obligations accrued prior to termination. The survival period for each surviving provision shall be as specified in the relevant section, or, if no period is specified, shall continue indefinitely to the extent necessary to give full effect to the Parties' intent as expressed in such provision.
Counterparts
02/26/2026 GenericEnhancedY
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same agreement. Execution and delivery of this Agreement by exchange of facsimile copies or electronically transmitted copies bearing the facsimile or electronic signature of a Party shall constitute a valid and binding execution and delivery of this Agreement by such Party. Such facsimile or electronic copies shall constitute enforceable original documents. The Parties agree that electronic signatures, whether digital or encrypted, shall have the same legal effect, validity, and enforceability as a manually executed signature to the fullest extent permitted by applicable law, including the Federal Electronic Signatures in Global and National Commerce Act (E-SIGN) and the Uniform Electronic Transactions Act (UETA).
HIPAA Notice of Privacy Practices
02/26/2026 GenericEnhancedY
Notice of Privacy Practices. This notice describes how medical information about you may be used and disclosed and how you can get access to this information. Please review it carefully. We are required by law to maintain the privacy of your Protected Health Information (PHI), to provide you with notice of our legal duties and privacy practices with respect to PHI, and to notify affected individuals following a breach of unsecured PHI. We are required to abide by the terms of this Notice. We reserve the right to change the terms of this Notice and to make new provisions effective for all PHI that we maintain. We may use and disclose your PHI for purposes of treatment, payment, and healthcare operations without your written authorization. For uses and disclosures beyond those permitted or required by law, we will obtain your written authorization before using or disclosing your PHI. You have the right to revoke such authorization at any time in writing, except to the extent that we have already taken action in reliance upon such authorization. You have the right to request restrictions on certain uses and disclosures, the right to receive confidential communications, the right to inspect and copy your PHI, and the right to amend your PHI.
Informed Consent
02/26/2026 GenericEnhancedY
Informed Consent. I, the undersigned patient (or authorized representative), hereby consent to the procedure(s) or treatment(s) described herein, which have been recommended by my treating physician. The nature and purpose of the proposed procedure(s), the expected benefits, the material risks, and the available alternatives (including the option of no treatment) have been explained to me in language I understand. I acknowledge that medicine is not an exact science and that no guarantees have been made to me regarding the results of the procedure(s) or treatment(s). I have had the opportunity to ask questions, and all my questions have been answered to my satisfaction. I understand that I have the right to withdraw my consent at any time prior to the commencement of the procedure(s). I authorize the disposal of any tissues, specimens, or body parts removed during the procedure in accordance with customary medical practices. I consent to the administration of anesthesia as deemed appropriate by the anesthesiologist or other qualified professional. This consent is given voluntarily and without coercion.
Business Associate Agreement
02/26/2026 GenericEnhancedY
Business Associate Agreement. The Business Associate agrees to: (a) not use or disclose Protected Health Information (PHI) other than as permitted or required by this Agreement or as required by law; (b) use appropriate safeguards, and comply with Subpart C of 45 CFR Part 164 with respect to electronic PHI, to prevent use or disclosure of PHI other than as provided for by this Agreement; (c) report to the Covered Entity any use or disclosure of PHI not provided for by this Agreement of which it becomes aware, including any breach of unsecured PHI as required by 45 CFR 164.410; (d) in accordance with 45 CFR 164.502(e)(1)(ii) and 164.308(b)(2), ensure that any subcontractors that create, receive, maintain, or transmit PHI on behalf of the Business Associate agree in writing to the same restrictions, conditions, and requirements that apply to the Business Associate under this Agreement; (e) make available PHI as necessary to satisfy the Covered Entity's obligations to provide individuals with access to their PHI pursuant to 45 CFR 164.524; (f) make its internal practices, books, and records relating to the use and disclosure of PHI available to the Secretary of the Department of Health and Human Services for purposes of determining the Covered Entity's compliance with the HIPAA Rules.
Breach Notification
02/26/2026 GenericEnhancedY
Breach Notification. In the event of a breach of unsecured Protected Health Information (PHI), the Covered Entity shall notify each individual whose unsecured PHI has been, or is reasonably believed to have been, accessed, acquired, used, or disclosed as a result of such breach, without unreasonable delay and in no case later than sixty (60) calendar days after the discovery of the breach, as required under 45 CFR 164.404. The notification shall include: (a) a brief description of what happened, including the date of the breach and the date of discovery; (b) a description of the types of unsecured PHI involved in the breach; (c) any steps the individual should take to protect themselves from potential harm resulting from the breach; (d) a brief description of what the Covered Entity is doing to investigate the breach, to mitigate harm to individuals, and to protect against any further breaches; and (e) contact procedures for individuals to ask questions, including a toll-free telephone number, e-mail address, website, or postal address. If a breach affects 500 or more individuals in a State or jurisdiction, the Covered Entity shall provide notice to prominent media outlets serving the State or jurisdiction and shall notify the Secretary of HHS contemporaneously with the individual notifications.
Patient Bill of Rights
02/26/2026 GenericEnhancedY
Patient Bill of Rights. Every patient receiving care at this facility has the right to: (a) receive treatment without discrimination based on race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, or source of payment; (b) receive considerate and respectful care in a clean and safe environment, free from all forms of abuse, harassment, and neglect; (c) be informed of the name and credentials of the healthcare provider responsible for coordinating their care; (d) receive complete and current information concerning their diagnosis, treatment, and prognosis in terms they can understand; (e) refuse treatment to the extent permitted by law and to be informed of the medical consequences of such refusal; (f) formulate advance directives and have hospital staff comply with those directives; (g) have their privacy and confidentiality protected in accordance with all applicable state and federal laws, including HIPAA; (h) review their medical records and obtain copies within a reasonable timeframe; (i) be informed of any experimental or research treatments proposed and to refuse participation without compromise to their care; and (j) receive an itemized bill upon request and have charges explained.
Patient Authorization for Disclosure
02/26/2026 GenericEnhancedY
Patient Authorization for Disclosure of PHI. I hereby authorize the use and/or disclosure of my individually identifiable health information as described below. I understand that this authorization is voluntary and that I may refuse to sign this authorization. My treatment, payment, enrollment, or eligibility for benefits will not be conditioned on whether I sign this authorization, unless the authorization is for the purpose of creating PHI for disclosure to a third party. I understand that I may revoke this authorization at any time by submitting a written revocation, except to the extent that action has already been taken in reliance on this authorization. I understand that information disclosed pursuant to this authorization may be subject to re-disclosure by the recipient and may no longer be protected by federal privacy regulations. This authorization shall expire on [Date] or upon [Event], whichever occurs first. If no expiration date or event is specified, this authorization shall expire twelve (12) months from the date signed.
Emergency Treatment Consent
02/26/2026 GenericEnhancedY
Emergency Treatment Consent. In the event of an emergency in which I am unable to provide informed consent due to my medical condition, I authorize the physicians and healthcare professionals at this facility to perform such diagnostic procedures, treatments, and medical or surgical interventions as they deem necessary and appropriate to address the emergency condition. I understand that this consent applies only to emergency situations where delay in treatment would pose a threat to my life, health, or result in permanent impairment of a bodily function. I acknowledge that this emergency consent does not replace the requirement for informed consent for any subsequent non-emergency procedures. If I have previously executed an advance directive, living will, or healthcare power of attorney, I request that the provisions of such documents be honored to the extent feasible under the emergency circumstances.
Advance Directive Notice
02/26/2026 GenericEnhancedY
Advance Directive Notice. In accordance with the Patient Self-Determination Act (42 U.S.C. § 1395cc(f)) and applicable state law, this facility is required to inform you of your rights under state law to make decisions concerning your medical care, including the right to accept or refuse medical or surgical treatment and the right to formulate advance directives. An advance directive is a written document, such as a living will or durable power of attorney for healthcare, that communicates your wishes regarding medical treatment in the event you become unable to make decisions for yourself. This facility will: (a) provide you with written information about your rights under state law to make decisions concerning your medical care; (b) document in your medical record whether you have executed an advance directive; (c) not condition the provision of care or otherwise discriminate against you based on whether you have executed an advance directive; and (d) ensure compliance with state law requirements regarding advance directives. You are encouraged to discuss advance directives with your physician and your family.
Quality Control & Deviation Handling
02/26/2026 GenericEnhancedY
Quality Control and Deviation Handling. The Manufacturer shall establish, maintain, and comply with a quality management system that meets the requirements of ISO 9001:2015 (or equivalent standard as agreed by the Parties) throughout the term of this Agreement. All products shall be manufactured in accordance with the agreed-upon Specifications, current Good Manufacturing Practices (cGMP), and applicable regulatory requirements. In the event of any deviation from approved processes, specifications, or procedures, the Manufacturer shall immediately notify the Quality Assurance department and initiate a formal deviation investigation within twenty-four (24) hours. The deviation report shall include root cause analysis, impact assessment, corrective actions, and preventive measures. No deviated product shall be released without written approval from the authorized Quality representative. The Manufacturer shall maintain complete and accurate batch records and make them available for review upon request. All deviations, corrective actions, and preventive actions (CAPA) shall be documented and tracked to closure.
Change Control
02/26/2026 GenericEnhancedY
Change Control. No changes to approved processes, materials, equipment, specifications, manufacturing site, or testing methods shall be implemented without prior written approval through the formal change control process. The Party initiating a change shall submit a Change Control Request that includes: (a) a detailed description of the proposed change; (b) the rationale and justification for the change; (c) a risk assessment of the potential impact on product quality, safety, and efficacy; (d) a validation or qualification plan, if applicable; (e) a regulatory impact assessment identifying any required submissions or notifications to regulatory authorities; and (f) a proposed implementation timeline. Both Parties shall review and approve all Change Control Requests prior to implementation. Changes classified as major shall require regulatory approval before implementation. The Manufacturer shall maintain a complete change control log documenting all changes, their classification, approval dates, and implementation status.
Supplier Qualification & Auditing
02/26/2026 GenericEnhancedY
Supplier Qualification and Auditing. The Manufacturer shall maintain a documented supplier qualification program that ensures all suppliers and sub-suppliers of raw materials, components, and services meet the quality and regulatory requirements established under this Agreement. Supplier qualification shall include, at a minimum: (a) initial assessment through a supplier qualification questionnaire and documentation review; (b) an on-site audit prior to approval for critical material suppliers; (c) evaluation of the supplier's quality management system, including ISO or cGMP certifications; (d) review and approval of certificates of analysis (CoA) and certificates of conformance (CoC) for all incoming materials; and (e) ongoing monitoring through periodic re-audits, performance scorecards, and trend analysis of incoming material quality. The Client reserves the right to audit the Manufacturer's suppliers upon reasonable notice. Any supplier found to be non-compliant shall be placed on probation or disqualified, with a corrective action plan required before reinstatement.
Product Recall Procedures
02/26/2026 GenericEnhancedY
Product Recall Procedures. The Manufacturer shall maintain a documented product recall procedure that can be initiated within twenty-four (24) hours of a recall decision. The recall procedure shall include: (a) a designated recall coordinator with authority to initiate and manage recall activities; (b) a communication plan for notifying the Client, regulatory authorities, distributors, and affected customers; (c) a traceability system capable of identifying all affected lot numbers, distribution channels, and customer shipments within four (4) hours; (d) procedures for segregation, quarantine, return, and disposition of recalled product; (e) a root cause investigation process to determine the cause of the recall and prevent recurrence; (f) a mock recall exercise conducted at least annually to verify the effectiveness of the recall system; and (g) documentation and retention of all recall records for a minimum period as required by applicable regulations. The Manufacturer shall bear all costs associated with a recall caused by its failure to comply with Specifications, cGMP requirements, or the terms of this Agreement.
Document Control
02/26/2026 GenericEnhancedY
Document Control. The Manufacturer shall establish and maintain a document control system that governs the creation, review, approval, distribution, revision, and retirement of all quality-related documents, including but not limited to standard operating procedures (SOPs), work instructions, specifications, batch records, validation protocols, and quality agreements. All documents shall be uniquely identified with a document number, revision level, and effective date. Documents shall not be implemented until formally approved by authorized personnel through the document management system. Obsolete documents shall be promptly removed from all points of use and archived in accordance with applicable retention requirements. The Manufacturer shall maintain a master document list that identifies the current revision status of all controlled documents. Any changes to controlled documents shall be processed through the change control system and shall require the same level of review and approval as the original document.
Equipment Calibration & Maintenance
02/26/2026 GenericEnhancedY
Equipment Calibration and Maintenance. The Manufacturer shall establish and maintain a preventive maintenance and calibration program for all equipment, instruments, and measuring devices used in the manufacture, testing, and storage of products. All critical instruments shall be calibrated at defined intervals using standards traceable to the National Institute of Standards and Technology (NIST) or equivalent national metrology body. Calibration records shall include the instrument identification number, calibration date, calibration results (as-found and as-left readings), acceptance criteria, next calibration due date, and the identity of the person performing the calibration. Any instrument found to be out of calibration shall trigger an investigation to assess the impact on product quality for all batches tested or manufactured since the last successful calibration. Equipment preventive maintenance shall be performed according to a documented schedule, and maintenance records shall be maintained for the life of the equipment. Equipment shall be clearly labeled with its calibration or maintenance status.
Environmental Health & Safety
02/26/2026 GenericEnhancedY
Environmental Health and Safety. The Manufacturer shall comply with all applicable environmental, health, and safety (EHS) laws, regulations, and standards, including but not limited to the Occupational Safety and Health Act (OSHA), the Resource Conservation and Recovery Act (RCRA), the Clean Air Act, and the Clean Water Act. The Manufacturer shall maintain an EHS management system that includes: (a) documented safety procedures for all manufacturing operations; (b) a hazard communication program including Safety Data Sheets (SDS) for all chemicals used; (c) personal protective equipment (PPE) requirements and training; (d) emergency response and evacuation procedures; (e) waste management procedures ensuring proper classification, storage, labeling, transportation, and disposal of all hazardous and non-hazardous waste; (f) an incident investigation and reporting program for all workplace injuries, illnesses, near-misses, and environmental releases; and (g) regular EHS audits and inspections. The Manufacturer shall promptly notify the Client of any EHS incidents that may affect product quality or regulatory compliance.
Training Requirements
02/26/2026 GenericEnhancedY
Training Requirements. The Manufacturer shall establish and maintain a training program that ensures all personnel involved in the manufacture, testing, storage, and distribution of products are adequately trained and qualified to perform their assigned duties. Training shall include, at a minimum: (a) initial training prior to performing any job function, including cGMP requirements, SOPs applicable to the employee's role, and safety procedures; (b) periodic retraining at defined intervals, not to exceed two (2) years, to ensure continued competency; (c) training on all revised or new SOPs prior to their effective date; (d) job-specific technical training for specialized operations such as aseptic processing, analytical testing, and equipment operation; and (e) documentation of all training activities, including the training date, subject matter, trainer credentials, and trainee assessment results. Training records shall be maintained in individual training files for each employee and shall be available for review during audits. Personnel shall not perform any task for which they have not been trained and deemed competent.
Anti-Money Laundering (AML) Policy
02/26/2026 GenericEnhancedY
Anti-Money Laundering Policy Statement. This institution is committed to full compliance with all applicable anti-money laundering (AML) laws and regulations, including but not limited to the Bank Secrecy Act (BSA), the USA PATRIOT Act, and all regulations promulgated by the Financial Crimes Enforcement Network (FinCEN). This institution shall establish and maintain an effective AML compliance program that includes: (a) the designation of a qualified BSA/AML Compliance Officer responsible for the day-to-day oversight of the compliance program; (b) the development and implementation of internal policies, procedures, and controls designed to detect and report suspicious activity; (c) ongoing, risk-based employee training at all levels of the organization; (d) independent testing of the AML program on a periodic basis; and (e) a risk-based Customer Identification Program (CIP) and Customer Due Diligence (CDD) process, including Enhanced Due Diligence (EDD) for higher-risk customers. All employees are required to report any known or suspected suspicious activity to the BSA/AML Compliance Officer immediately. Failure to comply with this policy may result in disciplinary action, up to and including termination of employment and referral for criminal prosecution.
Know Your Customer (KYC)
02/26/2026 GenericEnhancedY
Know Your Customer Policy. This institution shall implement and maintain a risk-based Know Your Customer (KYC) program to verify the identity of all customers and to understand the nature and purpose of customer relationships in order to develop a customer risk profile. For individual customers, identity verification shall include the collection and verification of, at a minimum: full legal name, date of birth, residential address, and a government-issued identification number (such as a Social Security Number, passport number, or driver's license number). For entity customers, the institution shall obtain: legal name and form of organization, principal place of business, Employer Identification Number (EIN) or equivalent, and identification of all beneficial owners holding twenty-five percent (25%) or more ownership interest. Customer risk profiles shall be reviewed and updated periodically, or upon the occurrence of a triggering event such as unusual transaction activity, significant change in account behavior, or adverse media. High-risk customers shall be subject to Enhanced Due Diligence (EDD), which may include senior management approval, more frequent reviews, and additional documentation requirements.
Suspicious Activity Reporting
02/26/2026 GenericEnhancedY
Suspicious Activity Reporting. All employees are required to be vigilant for indicators of suspicious activity and to promptly report any such activity to the BSA/AML Compliance Officer or through the institution's designated reporting channels. The BSA/AML Compliance Officer shall evaluate all reports of suspicious activity and, where warranted, shall file a Suspicious Activity Report (SAR) with the Financial Crimes Enforcement Network (FinCEN) within thirty (30) calendar days of the initial detection of facts that may constitute a basis for filing. If no suspect has been identified, the filing deadline may be extended to sixty (60) days. A SAR shall be filed for any transaction or pattern of transactions that involves or aggregates at least $5,000 in funds or other assets and the institution knows, suspects, or has reason to suspect that: (a) the transaction involves funds derived from illegal activity; (b) the transaction is designed to evade BSA reporting requirements; (c) the transaction has no business or apparent lawful purpose; or (d) the transaction involves the use of the institution to facilitate criminal activity. SAR filings are confidential and shall not be disclosed to any person involved in the reported transaction.
Fair Lending Policy
02/26/2026 GenericEnhancedY
Fair Lending Policy. This institution is committed to fair lending practices and full compliance with all applicable fair lending laws and regulations, including the Equal Credit Opportunity Act (ECOA), the Fair Housing Act (FHA), the Home Mortgage Disclosure Act (HMDA), and the Community Reinvestment Act (CRA). It is the policy of this institution that no applicant shall be discouraged from applying for credit, nor shall any applicant be denied credit, on the basis of race, color, religion, national origin, sex, marital status, age (provided the applicant has the capacity to contract), receipt of income from any public assistance program, or the good faith exercise of any right under the Consumer Credit Protection Act. All lending decisions shall be based on the applicant's creditworthiness as evaluated through objective, consistently applied underwriting standards. The institution shall conduct periodic fair lending analyses, including regression analysis of loan pricing and denial rates, to identify and address any potential disparate treatment or disparate impact. All lending personnel shall receive fair lending training at least annually.
Consumer Privacy Notice (Gramm-Leach-Bliley)
02/26/2026 GenericEnhancedY
Consumer Privacy Notice. In accordance with the Gramm-Leach-Bliley Act (GLBA), Title V, and Regulation P (12 CFR Part 1016), this institution provides the following notice regarding the collection, use, and sharing of nonpublic personal information (NPI). We collect NPI from the following sources: (a) information you provide on applications and other forms, such as your name, address, Social Security number, assets, and income; (b) information about your transactions with us, our affiliates, or others, such as your account balance, payment history, and account activity; and (c) information we receive from consumer reporting agencies, such as your credit history and creditworthiness. We do not disclose NPI about our customers or former customers to nonaffiliated third parties, except as permitted by law. You have the right to opt out of certain disclosures of NPI to nonaffiliated third parties. We restrict access to NPI about you to those employees and authorized agents who need to know that information to provide products or services to you. We maintain physical, electronic, and procedural safeguards that comply with federal standards to guard your NPI.
Electronic Fund Transfer Disclosure
02/26/2026 GenericEnhancedY
Electronic Fund Transfer Disclosure. In accordance with the Electronic Fund Transfer Act (EFTA) and Regulation E (12 CFR Part 1005), this disclosure describes your rights and responsibilities regarding electronic fund transfers (EFTs) to and from your account. EFTs include, but are not limited to: automated teller machine (ATM) transactions, point-of-sale (POS) debit card transactions, direct deposits, preauthorized transfers, telephone transfers, and online or mobile banking transactions. If you believe your debit card or access credentials have been lost or stolen, or that someone has transferred or may transfer money from your account without your permission, contact us immediately. Your liability for unauthorized transfers depends on how quickly you report the loss: if reported within two (2) business days, your liability shall not exceed $50; if reported after two (2) business days but within sixty (60) calendar days of receipt of your statement, your liability shall not exceed $500; if reported after sixty (60) calendar days, you may be liable for the full amount of the unauthorized transfer. We will provide you with a periodic statement for each monthly cycle in which an EFT occurs, and at least quarterly if no EFT occurs.
OFAC Sanctions Compliance
02/26/2026 GenericEnhancedY
OFAC Sanctions Compliance. This institution shall maintain a comprehensive sanctions compliance program in accordance with the regulations administered by the Office of Foreign Assets Control (OFAC) of the U.S. Department of the Treasury. The institution shall screen all customers, transactions, and counterparties against the OFAC Specially Designated Nationals and Blocked Persons (SDN) List, the Consolidated Sanctions List, and all applicable country-based and program-based sanctions. Screening shall be conducted: (a) at the time of account opening or customer onboarding; (b) upon receipt of incoming wire transfers and before processing outgoing wire transfers; (c) when processing trade finance or letter of credit transactions; (d) upon any update to the OFAC sanctions lists; and (e) at such other intervals as risk-based procedures may require. All potential matches (hits) shall be investigated and resolved by trained compliance personnel. Confirmed matches shall be reported to OFAC, the associated funds or property shall be blocked or rejected as required, and a report shall be filed within ten (10) business days. The institution shall maintain all records related to blocked or rejected transactions for a minimum of five (5) years.
21 CFR Part 11 Electronic Records Compliance
02/26/2026 GenericEnhancedY
Electronic Records and Electronic Signatures Compliance. All electronic records and electronic signatures created, modified, maintained, archived, retrieved, or transmitted under this system shall comply with the requirements of Title 21 of the Code of Federal Regulations, Part 11 (21 CFR Part 11). The system shall employ procedures and controls designed to ensure the authenticity, integrity, and confidentiality of electronic records, including: (a) validation of systems to ensure accuracy, reliability, consistent intended performance, and the ability to discern invalid or altered records; (b) the ability to generate accurate and complete copies of records in both human-readable and electronic form; (c) protection of records to enable their accurate and ready retrieval throughout the records retention period; (d) limiting system access to authorized individuals; (e) use of secure, computer-generated, time-stamped audit trails to independently record the date and time of operator entries and actions that create, modify, or delete electronic records; and (f) use of authority checks to ensure that only authorized individuals can use the system, electronically sign a record, access the operation or computer system input or output device, alter a record, or perform the operation at hand. Electronic signatures shall be unique to one individual and shall not be reused by or reassigned to anyone else.
Adverse Event Reporting
02/26/2026 GenericEnhancedY
Adverse Event Reporting. The Sponsor and all Investigators shall comply with all applicable adverse event reporting requirements as set forth in 21 CFR Parts 312 and 314 for drugs, 21 CFR Part 803 for medical devices, and ICH E2A guidelines for clinical safety data management. All serious adverse events (SAEs) shall be reported to the Sponsor within twenty-four (24) hours of the Investigator first becoming aware of the event. An SAE is defined as any adverse event that results in: death, a life-threatening condition, inpatient hospitalization or prolongation of existing hospitalization, persistent or significant disability or incapacity, a congenital anomaly or birth defect, or any event that requires medical or surgical intervention to prevent one of the above outcomes. The Sponsor shall submit IND Safety Reports to the FDA and all participating Investigators within fifteen (15) calendar days of receiving the SAE report, or within seven (7) calendar days for events that are both serious and unexpected and associated with the use of the investigational product where the event is fatal or life-threatening. All adverse events, regardless of severity, shall be documented, assessed for causality, and followed until resolution or stabilization.
Product Labeling Requirements
02/26/2026 GenericEnhancedY
Product Labeling Requirements. All product labeling shall comply with the applicable requirements of Title 21 of the Code of Federal Regulations, including Part 201 (drug labeling), Part 801 (medical device labeling), or Part 101 (food labeling), as applicable. Labels shall include all required elements including, but not limited to: product name (proprietary and established), active ingredients and strength (for drugs), intended use or indications, directions for use, warnings, precautions, contraindications, adverse reactions, storage conditions, lot number or batch number, expiration date, and the name and address of the manufacturer, packer, or distributor. All labeling text shall be legible, conspicuous, and in the English language (with additional languages as required by the target market). Labeling changes shall be processed through the formal change control system and, where applicable, shall be submitted to the FDA for approval prior to implementation through a Prior Approval Supplement (PAS) or Changes Being Effected (CBE) supplement. The Manufacturer shall maintain specimen labels for each lot produced and shall retain labeling records as required by 21 CFR Part 211.186.
Validation Protocol
02/26/2026 GenericEnhancedY
Validation Protocol. This Validation Protocol establishes the documented evidence that provides a high degree of assurance that the specific process, method, equipment, or system consistently produces a result meeting its predetermined specifications and quality attributes, in accordance with 21 CFR Parts 210, 211, and 820, and applicable FDA Guidance for Industry. The validation shall follow the lifecycle approach consisting of: Stage 1 — Process Design, which includes defining the process and identifying critical process parameters (CPPs) and critical quality attributes (CQAs); Stage 2 — Process Qualification, which includes facility, utility, and equipment qualification (IQ/OQ/PQ), and Performance Qualification (PPQ) demonstrating that the process is capable of reproducible commercial manufacture; and Stage 3 — Continued Process Verification, which provides ongoing assurance that the process remains in a state of control during routine production. Acceptance criteria for each validation stage shall be predefined and documented. Any deviations from the validation protocol shall be documented, investigated, and assessed for their impact on validation conclusions. The validation shall not be considered complete until all acceptance criteria have been met and a final validation report has been approved by the Quality Unit.
Medical Device Complaint Handling
02/26/2026 GenericEnhancedY
Medical Device Complaint Handling. The manufacturer shall establish and maintain procedures for receiving, reviewing, investigating, and evaluating complaints relating to the quality, safety, or performance of medical devices, in accordance with 21 CFR 820.198 and the Quality System Regulation (QSR). A complaint is defined as any written, electronic, or oral communication that alleges deficiencies related to the identity, quality, durability, reliability, safety, effectiveness, or performance of a device after it is released for distribution. Each complaint shall be documented with: the date received, the name and contact information of the complainant, the device identification (model, lot/serial number), the nature of the complaint, the date and results of the investigation, any corrective action taken, and the date the complainant was notified of the resolution. Any complaint involving a death, serious injury, or malfunction that could cause or contribute to a death or serious injury shall be evaluated for Medical Device Report (MDR) filing obligations under 21 CFR Part 803. MDRs shall be submitted to the FDA within thirty (30) calendar days, or within five (5) days for events requiring remedial action to prevent an unreasonable risk of substantial harm to public health.
Good Laboratory Practices (GLP)
02/26/2026 GenericEnhancedY
Good Laboratory Practices Compliance. All nonclinical laboratory studies intended to support applications for research or marketing permits for products regulated by the FDA shall be conducted in compliance with Good Laboratory Practices (GLP) as specified in 21 CFR Part 58. The testing facility shall designate a Study Director who shall have overall responsibility for the technical conduct of the study, interpretation, analysis, documentation, and reporting of results. The facility shall establish a Quality Assurance Unit (QAU) that is entirely separate from and independent of the study conduct. The QAU shall monitor each study to assure management that the facilities, equipment, personnel, methods, practices, records, and controls are in conformance with GLP regulations. The QAU shall maintain a master schedule sheet of all studies conducted at the facility, shall inspect each study at intervals adequate to ensure the integrity of the study, and shall report any problems likely to affect study integrity to the Study Director and management immediately. All raw data, documentation, protocols, final reports, and specimens shall be retained for the period required by 21 CFR 58.195.
Post-Market Surveillance
02/26/2026 GenericEnhancedY
Post-Market Surveillance. The manufacturer shall establish and maintain a post-market surveillance system to proactively collect, analyze, and act upon information about the safety, performance, and quality of marketed products, in accordance with 21 CFR Part 822 (for medical devices), 21 CFR 314.80 (for drugs), and applicable FDA guidance. The post-market surveillance program shall include: (a) systematic monitoring of complaint data, adverse event reports, and Medical Device Reports (MDRs) or MedWatch reports; (b) analysis of product return data, field service reports, and warranty claims; (c) monitoring of published literature, clinical registries, and real-world evidence databases for safety signals related to the product or product class; (d) periodic review of post-market data to identify trends, emerging risks, or changes in the benefit-risk profile; (e) signal detection algorithms and statistical methodologies for early identification of safety concerns; and (f) procedures for implementing corrective actions, including field safety corrective actions, product recalls, or labeling changes, when warranted by post-market data. Post-market surveillance reports shall be submitted to regulatory authorities as required by applicable regulations and within the prescribed timeframes.
General Exclusions
02/26/2026 GenericEnhancedY
General Exclusions. This Policy does not apply to and the Insurer shall not be liable for any loss, damage, liability, claim, cost, or expense of any nature directly or indirectly arising out of, contributed to by, caused by, resulting from, or in connection with any of the following, regardless of any other cause or event contributing concurrently or in any other sequence to the loss: (a) war, invasion, acts of foreign enemies, hostilities or warlike operations (whether war is declared or not), civil war, mutiny, civil commotion assuming the proportions of or amounting to a popular uprising, military rising, insurrection, rebellion, revolution, military or usurped power, or any act of terrorism; (b) nuclear reaction, nuclear radiation, or radioactive contamination; (c) any dishonest, fraudulent, criminal, or malicious act or omission by the Insured or any person acting on behalf of the Insured; (d) wear and tear, gradual deterioration, inherent defect, or latent defect; (e) any loss or damage caused by or resulting from voluntary parting with title or possession of any property; or (f) any indirect or consequential loss of any kind unless specifically provided for elsewhere in this Policy.
Definitions
02/26/2026 GenericEnhancedY
Definitions. As used in this Policy, the following terms shall have the meanings set forth below: (a) "Insured" means the Named Insured shown in the Declarations and any person or organization qualifying as an insured under the terms of this Policy; (b) "Occurrence" means an accident, including continuous or repeated exposure to substantially the same general harmful conditions, which results in bodily injury or property damage neither expected nor intended from the standpoint of the Insured; (c) "Bodily Injury" means physical injury, sickness, or disease sustained by a person, including death resulting from any of these at any time; (d) "Property Damage" means physical injury to tangible property, including all resulting loss of use of that property, or loss of use of tangible property that is not physically injured; (e) "Coverage Territory" means the United States of America (including its territories and possessions), Puerto Rico, and Canada, or international waters or airspace, provided the injury or damage does not occur in the course of travel or transportation to or from any other country; (f) "Policy Period" means the period from the inception date to the expiration date shown in the Declarations, or any shorter period arising from cancellation; and (g) "Premium" means the amount shown in the Declarations as the total premium for this Policy, subject to adjustment as provided herein.
Conditions of Coverage
02/26/2026 GenericEnhancedY
Conditions of Coverage. The following conditions apply to this Policy and must be complied with by the Insured as a condition precedent to coverage: (a) the Named Insured shall pay all premiums when due; failure to pay any premium by the due date may result in cancellation of this Policy; (b) the Insured shall give the Insurer prompt written notice of any occurrence, claim, or suit that may result in a claim under this Policy, including the time, place, circumstances, and identity of any injured persons or witnesses; (c) the Insured shall cooperate fully with the Insurer in the investigation, settlement, and defense of any claim or suit; (d) the Insured shall not, except at the Insured's own cost, voluntarily make any payment, assume any obligation, or incur any expense without the prior written consent of the Insurer; (e) the Insured shall submit to examination under oath when required by the Insurer and shall produce all records and documents relating to any claim; (f) the Insured shall take all reasonable steps to protect property from further damage after a loss; and (g) the Insured shall not admit liability or settle any claim without the prior written consent of the Insurer.
Claims Procedures
02/26/2026 GenericEnhancedY
Claims Procedures. In the event of a loss or occurrence that may give rise to a claim under this Policy, the Insured shall: (a) notify the Insurer as soon as practicable, and in no event later than thirty (30) days after the date the Insured first becomes aware of the occurrence or claim; (b) provide a written proof of loss to the Insurer within ninety (90) days of the date of loss, containing all information and documentation requested by the Insurer to evaluate the claim; (c) protect the damaged property from further loss, make reasonable and necessary temporary repairs, and keep an accurate record of all repair expenses; (d) provide the Insurer with complete access to inspect damaged property and to examine the Insured's books and records as they relate to the claim; (e) submit to examination under oath at the Insurer's request; (f) cooperate fully with the Insurer's investigation and claims adjustment process; and (g) not dispose of any damaged property until authorized by the Insurer. The Insurer shall acknowledge receipt of the claim within fifteen (15) business days and shall communicate its coverage determination within a reasonable time, not to exceed the timeframe required by applicable state insurance regulations. In the event of a coverage dispute, the Insured retains the right to invoke the appraisal or arbitration provisions of this Policy.
Subrogation Rights
02/26/2026 GenericEnhancedY
Subrogation Rights. If the Insurer makes a payment under this Policy, the Insurer shall be subrogated to all of the Insured's rights of recovery against any person or organization responsible for the loss, to the extent of such payment. The Insured shall do nothing after a loss to impair or prejudice the Insurer's subrogation rights. The Insured shall execute and deliver any instruments and papers required and do whatever else is necessary to assist the Insurer in exercising its subrogation rights. Upon the Insurer's request, the Insured shall bring suit or transfer those rights to the Insurer and cooperate with the Insurer in any action or proceeding. Any amounts recovered through subrogation shall first be applied to reimburse the Insurer for its payment, including investigation and legal expenses, and the balance, if any, shall be paid to the Insured. The Insurer shall not exercise its subrogation rights against any Insured under this Policy unless the loss was caused by the intentional or fraudulent acts of that Insured.
Cancellation & Non-Renewal
02/26/2026 GenericEnhancedY
Cancellation and Non-Renewal. This Policy may be cancelled by the Named Insured at any time by providing written notice to the Insurer stating when thereafter the cancellation shall be effective. The Insurer may cancel this Policy by mailing written notice to the Named Insured at the address shown in the Declarations: (a) at least ten (10) days before the effective date of cancellation if the cancellation is for nonpayment of premium; or (b) at least thirty (30) days before the effective date of cancellation for any other reason permitted by applicable law, including but not limited to material misrepresentation in the application, substantial change in the risk assumed, or failure to comply with policy conditions. If this Policy is cancelled by the Insurer, the earned premium shall be computed pro rata. If cancelled by the Named Insured, the earned premium shall be computed in accordance with the short-rate table. Premium adjustment may be made either at the time cancellation is effected or as soon as practicable after cancellation becomes effective. If the Insurer elects not to renew this Policy, written notice of non-renewal shall be provided at least sixty (60) days prior to the expiration date, or as otherwise required by applicable state law.
Duties After Loss
02/26/2026 GenericEnhancedY
Duties After Loss. In the event of loss or damage to Covered Property, the Insured shall: (a) give prompt notice of the loss to the Insurer and to the police if the loss appears to involve a violation of law; (b) protect the property from further damage, make reasonable and necessary temporary repairs to protect the property, and keep an accurate record of all emergency and temporary repair expenses; (c) cooperate with the Insurer in the investigation and settlement of the claim; (d) prepare an inventory of all damaged personal property showing in detail the quantity, description, actual cash value, and amount of loss, and attach all bills, receipts, and related documentation; (e) as often as the Insurer reasonably requires, exhibit the damaged property, provide all records and documents requested, submit to examination under oath while not in the presence of any other Insured, and sign the transcript of such examination; (f) send a signed, sworn proof of loss to the Insurer within sixty (60) days after the loss, setting forth the facts required by the Insurer to determine its liability; and (g) not abandon property to the Insurer without the Insurer's prior written consent.
Data Processing Obligations (GDPR)
02/26/2026 GenericEnhancedY
Data Processing Obligations. The Data Processor shall process Personal Data only on documented instructions from the Data Controller, including with regard to transfers of Personal Data to a third country or an international organization, unless required to do so by Union or Member State law to which the Processor is subject; in such a case, the Processor shall inform the Controller of that legal requirement before processing, unless that law prohibits such information on important grounds of public interest. The Processor shall: (a) ensure that persons authorized to process the Personal Data have committed themselves to confidentiality or are under an appropriate statutory obligation of confidentiality; (b) take all measures required pursuant to Article 32 of the General Data Protection Regulation (GDPR), including implementing appropriate technical and organizational measures to ensure a level of security appropriate to the risk; (c) not engage another processor without prior specific or general written authorization of the Controller; (d) assist the Controller in responding to requests for exercising data subjects' rights; (e) assist the Controller in ensuring compliance with the obligations pursuant to Articles 32 to 36 of the GDPR; (f) at the choice of the Controller, delete or return all Personal Data to the Controller after the end of the provision of services; and (g) make available to the Controller all information necessary to demonstrate compliance with the obli...
Data Breach Notification
02/26/2026 GenericEnhancedY
Data Breach Notification. In the event of a Personal Data Breach, the Data Processor shall notify the Data Controller without undue delay, and in any event within forty-eight (48) hours after becoming aware of the breach, providing the Controller with sufficient information to enable the Controller to meet its obligations under Article 33 of the GDPR. The notification shall include: (a) a description of the nature of the Personal Data Breach, including the categories and approximate number of data subjects concerned, and the categories and approximate number of Personal Data records concerned; (b) the name and contact details of the Data Protection Officer or other contact point where more information can be obtained; (c) a description of the likely consequences of the Personal Data Breach; and (d) a description of the measures taken or proposed to be taken to address the Personal Data Breach, including measures to mitigate its possible adverse effects. Where it is not possible to provide all information at the same time, the information may be provided in phases without undue further delay. The Processor shall cooperate with the Controller and take all commercially reasonable steps to assist in the investigation, mitigation, and remediation of any such breach.
Data Subject Rights
02/26/2026 GenericEnhancedY
Data Subject Rights. The Data Controller shall implement appropriate technical and organizational measures to facilitate the exercise of data subject rights as provided under Chapter III of the GDPR, including: (a) Right of Access (Article 15) — the right to obtain confirmation as to whether Personal Data is being processed, and access to that data along with specified supplementary information; (b) Right to Rectification (Article 16) — the right to have inaccurate Personal Data rectified without undue delay; (c) Right to Erasure (Article 17) — the right to have Personal Data erased where there is no compelling reason for its continued processing; (d) Right to Restriction of Processing (Article 18) — the right to restrict processing in specified circumstances; (e) Right to Data Portability (Article 20) — the right to receive Personal Data in a structured, commonly used, and machine-readable format; (f) Right to Object (Article 21) — the right to object to processing based on legitimate interests, direct marketing, or research purposes; and (g) Rights related to automated decision-making and profiling (Article 22) — the right not to be subject to a decision based solely on automated processing that produces legal effects. All requests shall be responded to without undue delay and within one (1) month of receipt, subject to extension as permitted by the GDPR.
Cross-Border Data Transfer
02/26/2026 GenericEnhancedY
Cross-Border Data Transfer. No transfer of Personal Data to a third country or international organization shall take place unless adequate safeguards are in place as required by Chapter V of the GDPR. Approved transfer mechanisms include: (a) an adequacy decision by the European Commission pursuant to Article 45 of the GDPR, confirming that the recipient country ensures an adequate level of data protection; (b) Standard Contractual Clauses (SCCs) adopted by the European Commission pursuant to Article 46(2)(c) of the GDPR, supplemented by a Transfer Impact Assessment (TIA) where required; (c) Binding Corporate Rules (BCRs) approved by the competent supervisory authority pursuant to Article 47 of the GDPR for intra-group transfers; (d) an approved certification mechanism together with binding and enforceable commitments of the data importer pursuant to Article 42 of the GDPR; or (e) derogations for specific situations under Article 49 of the GDPR, applied on a case-by-case basis. The Data Controller and Data Processor shall maintain records documenting the legal basis for each international transfer and the supplementary measures implemented to ensure the protection of Personal Data is not undermined.
Data Retention Policy
02/26/2026 GenericEnhancedY
Data Retention Policy. Personal Data shall not be retained for longer than is necessary for the purposes for which it was collected and processed, in accordance with the principles of data minimization and storage limitation set forth in Article 5(1)(c) and (e) of the GDPR. The Data Controller shall establish and maintain a Data Retention Schedule that specifies, for each category of Personal Data: (a) the business or legal purpose for retention; (b) the maximum retention period, based on the applicable legal, regulatory, contractual, or operational requirements; (c) the criteria used to determine the retention period where a fixed period is not practicable; and (d) the method of secure destruction or anonymization upon expiration of the retention period. At the end of the applicable retention period, Personal Data shall be securely deleted, destroyed, or irreversibly anonymized such that the data subject can no longer be identified. Retention periods shall be reviewed annually and updated as necessary to reflect changes in legal requirements or business needs. This policy shall be communicated to all employees who process Personal Data, and compliance shall be monitored through periodic audits.
Privacy Impact Assessment
02/26/2026 GenericEnhancedY
Data Protection Impact Assessment. A Data Protection Impact Assessment (DPIA) shall be conducted prior to the commencement of any processing activity that is likely to result in a high risk to the rights and freedoms of natural persons, as required by Article 35 of the GDPR. A DPIA is required in particular where the processing involves: (a) systematic and extensive evaluation of personal aspects relating to natural persons based on automated processing, including profiling, on which decisions are based that produce legal effects or similarly significantly affect the data subjects; (b) processing on a large scale of special categories of data referred to in Article 9(1) or data relating to criminal convictions and offences referred to in Article 10; or (c) systematic monitoring of a publicly accessible area on a large scale. The DPIA shall contain at a minimum: a systematic description of the processing operations and their purposes, an assessment of the necessity and proportionality of the processing, an assessment of the risks to the rights and freedoms of data subjects, and the measures envisaged to address those risks. Where the DPIA indicates that the processing would result in a high risk in the absence of mitigation measures, the Controller shall consult with the supervisory authority prior to processing.
Cookie Policy & Consent
02/26/2026 GenericEnhancedY
Cookie Policy and Consent. This website uses cookies and similar tracking technologies in accordance with the ePrivacy Directive (2002/58/EC) as amended by Directive 2009/136/EC, and the General Data Protection Regulation (GDPR). Cookies are small text files placed on your device to enhance your browsing experience and to collect information about how you interact with our website. We categorize cookies as follows: (a) Strictly Necessary Cookies — essential for the operation of our website and do not require consent; (b) Functional Cookies — enable enhanced functionality and personalization and require your consent; (c) Analytics Cookies — help us understand how visitors interact with our website by collecting and reporting information anonymously and require your consent; and (d) Marketing Cookies — used to track visitors across websites and display relevant advertisements and require your consent. Before any non-essential cookies are placed on your device, we will request your informed, specific, and unambiguous consent through our cookie consent management platform. You may withdraw your consent at any time by accessing the cookie preferences center accessible via the link in the footer of each page. Withdrawal of consent shall not affect the lawfulness of processing based on consent before its withdrawal.
Non-Compete and Non-Solicitation
02/26/2026 GenericEnhancedY
Non-Compete and Non-Solicitation. During the term of employment and for a period of twelve (12) months following the termination of Employee's employment for any reason (the "Restricted Period"), Employee shall not, directly or indirectly, either individually or as a principal, partner, stockholder, manager, agent, consultant, contractor, employee, lender, investor, or in any other capacity: (a) engage in, own, manage, operate, control, be employed by, participate in, or be connected in any manner with the ownership, management, operation, or control of any business that competes with the Company's business within a fifty (50) mile radius of any office or facility maintained by the Company (the "Restricted Area"); (b) solicit, recruit, or attempt to hire any employee or independent contractor of the Company, or induce or encourage any such person to leave the service of the Company; or (c) solicit, divert, or take away, or attempt to solicit, divert, or take away, the business or patronage of any client, customer, or prospective customer of the Company with whom Employee had material contact during the last twenty-four (24) months of employment. Employee acknowledges that these restrictions are reasonable and necessary for the protection of the Company's legitimate business interests.
At-Will Employment
02/26/2026 GenericEnhancedY
At-Will Employment. Employee acknowledges and agrees that Employee's employment with the Company is at-will, meaning that either the Employee or the Company may terminate the employment relationship at any time, with or without cause, and with or without notice. Nothing in this Agreement, the Company's policies, practices, or statements by any representative of the Company shall be construed to create a contract of employment for a definite period or to alter the at-will nature of Employee's employment. No supervisor, manager, or other representative of the Company has the authority to enter into any agreement or make any representation to any employee that modifies the at-will nature of employment, except for a written agreement expressly authorized by and signed by the Chief Executive Officer or an authorized member of the Board of Directors. This at-will provision may not be modified, amended, or waived by any oral or written statement or conduct of any representative of the Company.
Intellectual Property Assignment
02/26/2026 GenericEnhancedY
Intellectual Property Assignment. Employee hereby irrevocably assigns to the Company all right, title, and interest in and to any and all Inventions, including all intellectual property rights therein, that are conceived, developed, created, or reduced to practice by Employee, either solely or jointly with others, during the term of employment and that: (a) relate to the Company's business, products, services, research, or development; (b) result from any work performed by Employee for the Company; or (c) are developed using the Company's equipment, supplies, facilities, or trade secret information. "Inventions" means all inventions, discoveries, improvements, ideas, concepts, original works of authorship, software, algorithms, designs, trade secrets, and any other intellectual property, whether or not patentable or registrable under copyright or similar laws. Employee shall promptly disclose all Inventions to the Company in writing and shall execute all documents and take all actions reasonably requested by the Company to perfect, register, and enforce the Company's rights in such Inventions, including assignments, patent applications, and copyright registrations. Employee acknowledges that all copyrightable works created within the scope of employment are works made for hire as defined under the Copyright Act of 1976.
Confidentiality & Trade Secrets
02/26/2026 GenericEnhancedY
Confidentiality and Trade Secrets. During the term of employment and at all times thereafter, Employee shall hold in strict confidence and shall not, without the prior written consent of the Company, directly or indirectly, use or disclose to any person or entity any Confidential Information or Trade Secrets of the Company. "Confidential Information" includes, without limitation: business plans, strategies, financial data, customer lists, pricing information, vendor information, marketing plans, product roadmaps, technical specifications, manufacturing processes, research data, software code, algorithms, and personnel records. "Trade Secrets" means information that derives independent economic value from not being generally known to the public or to competitors and is the subject of reasonable efforts to maintain its secrecy, as defined under the Defend Trade Secrets Act (DTSA) and applicable state law. Employee acknowledges that the unauthorized disclosure of Trade Secrets may subject Employee to liability under both this Agreement and federal law, including injunctive relief and damages under the DTSA (18 U.S.C. § 1836). Pursuant to the DTSA, Employee is hereby notified that Employee shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret made in confidence to a government official or attorney solely for the purpose of reporting or investigating a suspected violation of law.
Equal Employment Opportunity
02/26/2026 GenericEnhancedY
Equal Employment Opportunity. The Company is an equal opportunity employer and is committed to providing a work environment free of discrimination and harassment. It is the policy of the Company to comply with all applicable federal, state, and local laws prohibiting discrimination based on race, color, religion, sex (including pregnancy, childbirth, and related medical conditions), sexual orientation, gender identity, national origin, age, disability, genetic information, veteran status, citizenship status, or any other characteristic protected by applicable law. This policy applies to all terms and conditions of employment, including but not limited to recruitment, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, benefits, and training. The Company will make reasonable accommodations for qualified individuals with known disabilities unless doing so would result in an undue hardship to the business. Employees who believe they have been subjected to discrimination or harassment should report the matter immediately to their supervisor, the Human Resources Department, or through the Company's anonymous reporting hotline.
Whistleblower Protection
02/26/2026 GenericEnhancedY
Whistleblower Protection. The Company is committed to maintaining the highest standards of ethical conduct and legal compliance and encourages employees to report, in good faith, any suspected violations of law, regulations, Company policies, or ethical standards through the Company's designated reporting channels, including the anonymous ethics hotline and the Compliance Officer. No employee who in good faith reports a suspected violation shall be subject to retaliation, including but not limited to discharge, demotion, suspension, threats, harassment, or any other form of adverse employment action. This protection extends to employees who participate in investigations, hearings, or proceedings related to such reports. Employees who report in good faith are protected under applicable federal and state whistleblower protection laws, including the Sarbanes-Oxley Act (SOX), the Dodd-Frank Wall Street Reform and Consumer Protection Act, and applicable state whistleblower statutes. Any employee who retaliates against an employee for making a good faith report shall be subject to disciplinary action, up to and including termination of employment. Reports may be made anonymously; however, providing identifying information may facilitate a more thorough investigation.
FMLA Notice
02/26/2026 GenericEnhancedY
Family and Medical Leave Act Notice. Eligible employees are entitled to take unpaid, job-protected leave for specified family and medical reasons under the Family and Medical Leave Act (FMLA), 29 U.S.C. § 2601 et seq. To be eligible, an employee must have worked for the Company for at least twelve (12) months, have worked at least 1,250 hours during the twelve-month period preceding the start of leave, and work at a location where the Company employs at least fifty (50) employees within seventy-five (75) miles. Eligible employees may take up to twelve (12) workweeks of unpaid leave in a twelve-month period for: (a) the birth of a child and to care for the newborn within one year of birth; (b) the placement of a child with the employee for adoption or foster care within one year of placement; (c) to care for the employee's spouse, child, or parent who has a serious health condition; or (d) a serious health condition that makes the employee unable to perform the essential functions of his or her job. Additionally, eligible employees may take up to twenty-six (26) workweeks of leave during a single twelve-month period to care for a covered servicemember with a serious injury or illness. Upon return from FMLA leave, the employee shall be restored to the same position or an equivalent position with equivalent benefits, pay, and other terms and conditions of employment.
Federal Acquisition Regulation (FAR) Compliance
02/26/2026 GenericEnhancedY
Federal Acquisition Regulation Compliance. The Contractor represents and certifies that it is in compliance with all applicable provisions of the Federal Acquisition Regulation (FAR), including but not limited to: FAR 52.203-13 (Contractor Code of Business Ethics and Conduct); FAR 52.222-26 (Equal Opportunity); FAR 52.222-35 (Equal Opportunity for Veterans); FAR 52.222-36 (Equal Opportunity for Workers with Disabilities); FAR 52.222-50 (Combating Trafficking in Persons); FAR 52.223-6 (Drug-Free Workplace); and FAR 52.225-13 (Restrictions on Certain Foreign Purchases). The Contractor shall maintain an effective internal control system that provides reasonable assurance that the management of the Contractor is in compliance with applicable laws and regulations. The Contractor shall timely disclose to the Government whenever, in connection with the award, performance, or closeout of this contract, the Contractor has credible evidence that a principal, employee, agent, or subcontractor of the Contractor has committed a violation of Federal criminal law involving fraud, conflict of interest, bribery, or gratuity violations or a violation of the civil False Claims Act. Failure to make required disclosures may result in contract termination, suspension, or debarment.
Export Control (ITAR/EAR)
02/26/2026 GenericEnhancedY
Export Control Compliance. The Contractor shall comply with all applicable export control laws and regulations, including the International Traffic in Arms Regulations (ITAR), 22 CFR Parts 120-130, administered by the Directorate of Defense Trade Controls (DDTC) of the U.S. Department of State, and the Export Administration Regulations (EAR), 15 CFR Parts 730-774, administered by the Bureau of Industry and Security (BIS) of the U.S. Department of Commerce. The Contractor acknowledges that technical data, defense articles, defense services, and items subject to the EAR provided under or generated in connection with this contract may be export-controlled and that unauthorized export or re-export is a violation of federal law subject to criminal and civil penalties. The Contractor shall: (a) determine the export classification (USML category or ECCN) of all items, technical data, and software; (b) obtain all required export licenses or authorizations prior to any export or deemed export; (c) screen all parties to transactions against the Consolidated Screening List; (d) maintain records of all exports and deemed exports as required by law; and (e) immediately report any known or suspected violations to the appropriate government authority and to the Contracting Officer.
Cybersecurity (CMMC/NIST 800-171)
02/26/2026 GenericEnhancedY
Cybersecurity Requirements. The Contractor shall implement and maintain cybersecurity controls sufficient to safeguard Controlled Unclassified Information (CUI) in accordance with the security requirements specified in NIST Special Publication 800-171 Revision 2, "Protecting Controlled Unclassified Information in Nonfederal Systems and Organizations," and DFARS 252.204-7012, "Safeguarding Covered Defense Information and Cyber Incident Reporting." The Contractor shall: (a) provide adequate security on all covered contractor information systems that process, store, or transmit CUI; (b) report cyber incidents that affect a covered contractor information system or the CUI residing therein to the DoD Cyber Crime Center (DC3) within seventy-two (72) hours of discovery; (c) submit malicious software discovered and isolated in connection with a reported cyber incident to DC3; (d) preserve and protect images of all known affected information systems and all relevant monitoring and packet capture data for at least ninety (90) days to allow for forensic analysis; (e) achieve and maintain the appropriate Cybersecurity Maturity Model Certification (CMMC) level as specified in the contract requirements; and (f) flow down these requirements to all subcontractors that will process, store, or transmit CUI.
Small Business Subcontracting Plan
02/26/2026 GenericEnhancedY
Small Business Subcontracting Plan. In accordance with FAR 52.219-9 and the Small Business Act (15 U.S.C. § 637(d)), the Contractor shall submit and implement a Small Business Subcontracting Plan that sets forth percentage goals for the utilization of small business concerns, including small disadvantaged businesses (SDB), women-owned small businesses (WOSB), HUBZone small businesses, veteran-owned small businesses (VOSB), and service-disabled veteran-owned small businesses (SDVOSB) as subcontractors. The plan shall include: (a) separate percentage goals for each small business category expressed as a percentage of total subcontract dollars; (b) a description of the method used to develop the subcontracting goals; (c) the name of the individual who will administer the plan and a description of their duties; (d) a description of the efforts the Contractor will make to ensure small business concerns have an equitable opportunity to compete for subcontracts; (e) assurances that the Contractor will include the required FAR clause in all subcontracts that offer further subcontracting opportunities; and (f) assurances that the Contractor will submit timely and accurate Individual Subcontracting Reports (ISRs) and Summary Subcontracting Reports (SSRs) through the Electronic Subcontracting Reporting System (eSRS).
Cost Accounting Standards
02/26/2026 GenericEnhancedY
Cost Accounting Standards. The Contractor shall comply with all applicable Cost Accounting Standards (CAS) promulgated by the Cost Accounting Standards Board (CASB), 48 CFR Chapter 99, and shall follow cost accounting practices that are consistent, adequate, and in accordance with CAS requirements. This includes full CAS coverage requiring compliance with all nineteen (19) standards for contracts subject to 48 CFR 9903.201-2(a), or modified CAS coverage requiring compliance with CAS 401 (Consistency in Estimating, Accumulating, and Reporting Costs), CAS 402 (Consistency in Allocating Costs Incurred for the Same Purpose), CAS 405 (Accounting for Unallowable Costs), and CAS 406 (Cost Accounting Period) for contracts subject to modified coverage under 48 CFR 9903.201-2(b). The Contractor shall submit a Disclosure Statement (DS-1 or DS-2) as required and shall notify the Contracting Officer and the cognizant Federal agency official in writing of any cost accounting practice changes or CAS noncompliances within sixty (60) days. Any failure to comply with CAS requirements may result in contract price adjustments, withholding of payments, or other contractual remedies.
Organizational Conflict of Interest
02/26/2026 GenericEnhancedY
Organizational Conflict of Interest. The Contractor warrants that, to the best of its knowledge and belief, there are no relevant facts or circumstances that could give rise to an organizational conflict of interest (OCI), as defined in FAR 2.101 and FAR Subpart 9.5. An OCI exists when, because of other activities or relationships, a contractor is unable or potentially unable to render impartial assistance or advice to the Government, or the contractor's objectivity in performing the contract work is or might be otherwise impaired, or the contractor has an unfair competitive advantage. The Contractor agrees to: (a) disclose any potential or actual OCI to the Contracting Officer as soon as such conflict is identified; (b) implement an OCI mitigation plan approved by the Contracting Officer to avoid, neutralize, or mitigate any identified conflicts; (c) maintain an organizational firewall or other approved measures to prevent the flow of information that could create an unfair competitive advantage or bias; and (d) include appropriate OCI provisions in all subcontracts where a potential conflict exists. Failure to disclose or mitigate an OCI may result in termination of the contract, disqualification from future competitions, or other remedies available under law.
Property Disclosure Statement
02/26/2026 GenericEnhancedY
Property Disclosure Statement. The Seller hereby discloses the following information regarding the condition of the property located at [Property Address] to the best of Seller's actual knowledge as of the date signed. This disclosure is not a warranty of any kind by the Seller or the Seller's agent(s) and is not a substitute for any inspections or warranties the Buyer may wish to obtain. The Seller is aware of the following conditions: (a) structural systems, including foundation, roof, walls, and ceilings; (b) plumbing, electrical, heating, and air conditioning systems; (c) any history of water intrusion, flooding, drainage problems, or moisture damage; (d) the presence or prior existence of hazardous materials including asbestos, lead-based paint, radon, mold, or underground storage tanks; (e) any environmental contamination or remediation activity; (f) any known encroachments, easements, or boundary disputes; (g) any current or pending zoning violations, code violations, or governmental notices; (h) any defects in the title or liens against the property; (i) homeowners' association obligations, fees, and restrictions; and (j) any other material facts that could affect the value or desirability of the property. Seller acknowledges that failure to disclose known material defects may result in liability to the Buyer.
Lead-Based Paint Disclosure
02/26/2026 GenericEnhancedY
Lead-Based Paint Disclosure. In accordance with Section 1018 of the Residential Lead-Based Paint Hazard Reduction Act of 1992 (Title X) and 40 CFR Part 745, the following disclosures are made regarding lead-based paint and/or lead-based paint hazards in the property: Seller's Disclosure: (a) Seller is aware of the presence of lead-based paint and/or lead-based paint hazards in the property [Yes/No]; (b) Seller has provided the Buyer with all available records and reports pertaining to lead-based paint and/or lead-based paint hazards in the property [Yes/No]. Buyer's Acknowledgment: (c) Buyer has received the federally approved pamphlet "Protect Your Family From Lead in Your Home"; (d) Buyer has received ten (10) calendar days to conduct a risk assessment or inspection for the presence of lead-based paint and/or lead-based paint hazards [Buyer elects to conduct / waive inspection]; (e) Buyer has received all information listed above. Agent's Acknowledgment: Each agent has informed the Seller of the Seller's obligations under 42 U.S.C. § 4852d and is aware of its responsibilities to ensure compliance. Warning: Every purchaser of any interest in residential real property on which a residential dwelling was built prior to 1978 is notified that such property may present exposure to lead from lead-based paint that may place young children at risk of developing lead poisoning.
Easement & Right of Way
02/26/2026 GenericEnhancedY
Easement and Right of Way. The Grantor hereby grants and conveys to the Grantee, its successors, and assigns, a perpetual [or term of years] non-exclusive easement and right of way over, across, upon, and through the real property described in Exhibit A attached hereto (the "Servient Estate") for the purpose of [ingress and egress / utility installation and maintenance / drainage / other specified purpose]. The easement area shall be [width] feet in width, centered upon the line described in Exhibit B. The Grantee shall have the right to enter upon the easement area at all reasonable times for the purposes stated herein, including the right to construct, install, operate, maintain, repair, replace, and remove facilities and improvements reasonably necessary for the stated purpose. The Grantee shall restore the surface of the easement area to substantially the same condition as existed prior to any entry. The Grantor reserves the right to use the easement area for any purpose that does not unreasonably interfere with the Grantee's exercise of the rights granted herein. This easement shall run with the land and be binding upon and inure to the benefit of the Parties, their heirs, successors, and assigns. This easement may not be modified, amended, or extinguished except by a written instrument executed by both the owner of the Servient Estate and the holder of the easement.
Environmental Site Assessment
02/26/2026 GenericEnhancedY
Environmental Site Assessment. Prior to closing, the Buyer may, at Buyer's sole cost and expense, commission a Phase I Environmental Site Assessment (ESA) of the property in accordance with ASTM Standard E1527-21, "Standard Practice for Environmental Site Assessments: Phase I Environmental Site Assessment Process." The Phase I ESA shall include, at a minimum: (a) review of historical records, aerial photographs, topographic maps, fire insurance maps, and regulatory databases to identify recognized environmental conditions (RECs); (b) a site reconnaissance to observe current and past uses of the property and adjoining properties; (c) interviews with current and past owners, operators, and occupants of the property, and with local government officials; and (d) evaluation of all findings to identify the presence or likely presence of any hazardous substances or petroleum products under conditions that indicate an existing release, a past release, or a material threat of a release. If the Phase I ESA identifies any RECs, the Buyer may, at Buyer's option: (i) proceed with the transaction; (ii) commission a Phase II ESA involving sampling and laboratory analysis; or (iii) terminate this Agreement and receive a full refund of the earnest money deposit. Seller shall provide reasonable access to the property for the purposes of conducting the ESA.
Title Insurance Commitment
02/26/2026 GenericEnhancedY
Title Insurance Commitment. The title insurance company (the "Title Company") hereby commits to issue a policy of title insurance in accordance with the terms and conditions of this Commitment. Schedule A identifies the proposed insured, the amount of the policy, the interest in the property to be insured, and the estate or interest in the land described herein. Schedule B, Section 1 sets forth the requirements that must be met before the Title Company will issue the policy, including: (a) payment of the full consideration to the Seller; (b) instruments creating the estate or interest to be insured must be executed, delivered, and recorded; (c) payment of all applicable taxes, assessments, and charges; and (d) satisfaction of all requirements set forth in the Commitment. Schedule B, Section 2 sets forth the exceptions from coverage, which may include but are not limited to: liens, encumbrances, easements, restrictions, covenants, conditions, mineral reservations, rights of way, and any matters that would be disclosed by an accurate survey and inspection of the property. The Buyer shall have a period of [number] days from receipt of this Commitment to review and object to any exceptions. Any exceptions not objected to within this period shall be deemed accepted by the Buyer.
License Grant
02/26/2026 GenericEnhancedY
License Grant. Subject to the terms and conditions of this Agreement, Licensor hereby grants to Licensee a [non-exclusive/exclusive], [worldwide/territory-limited], [revocable/irrevocable], [sublicensable/non-sublicensable] license to use, reproduce, modify, distribute, display, and perform the Licensed Material solely for the purposes described in Exhibit A. The license granted herein is limited to the Field of Use specified in the Definitions section and does not include any rights not expressly granted herein. All rights not expressly granted to Licensee are reserved by Licensor. Nothing in this Agreement shall be construed as granting Licensee any ownership rights in the Licensed Material or any intellectual property rights of Licensor, whether by implication, estoppel, or otherwise. The license granted herein shall commence on the Effective Date and shall continue for the Term specified herein, unless earlier terminated in accordance with this Agreement. Licensee shall not use the Licensed Material in any manner that exceeds the scope of the license granted herein or for any purpose not authorized by this Agreement.
IP Ownership & Work for Hire
02/26/2026 GenericEnhancedY
Intellectual Property Ownership. All right, title, and interest in and to the Work Product, including all intellectual property rights therein, shall belong exclusively to the Client. To the extent that any Work Product qualifies as a "work made for hire" under Section 101 of the United States Copyright Act (17 U.S.C. § 101), the Parties agree that such Work Product is a work made for hire and the Client shall be deemed the author thereof. To the extent that any Work Product does not qualify as a work made for hire, the Contractor hereby irrevocably assigns to the Client all right, title, and interest in and to such Work Product, including all copyrights, patents, trade secrets, trademarks, and other intellectual property rights therein. The Contractor shall execute any documents and take any actions reasonably requested by the Client to evidence, perfect, or protect the Client's ownership of the Work Product, including patent applications, copyright registrations, and assignments. The Contractor retains no rights in the Work Product except as expressly granted in this Agreement. "Work Product" means all deliverables, inventions, discoveries, improvements, works of authorship, software, designs, specifications, documentation, and other materials created, conceived, or developed by the Contractor in connection with the services provided under this Agreement.
Patent Indemnification
02/26/2026 GenericEnhancedY
Patent Indemnification. The Licensor shall indemnify, defend, and hold harmless the Licensee, its affiliates, officers, directors, employees, agents, and successors from and against any and all claims, suits, actions, proceedings, losses, damages, liabilities, costs, and expenses (including reasonable attorneys' fees and court costs) arising out of or related to any claim that the Licensed Material, when used by the Licensee in accordance with the terms of this Agreement, infringes or misappropriates any patent, copyright, trademark, trade secret, or other intellectual property right of any third party. Licensor's obligations under this section are conditioned upon: (a) Licensee providing Licensor with prompt written notice of any such claim; (b) Licensee granting Licensor sole control of the defense and settlement of such claim; and (c) Licensee providing Licensor with reasonable cooperation in the defense of such claim at Licensor's expense. If the Licensed Material is held to infringe, Licensor shall, at its option and expense: (i) procure for Licensee the right to continue using the Licensed Material; (ii) modify the Licensed Material to make it non-infringing while maintaining substantially equivalent functionality; (iii) replace the Licensed Material with a non-infringing equivalent; or (iv) if none of the foregoing are commercially practicable, terminate the license and refund all fees paid by Licensee for the infringing Licensed Material.
Trademark Usage Guidelines
02/26/2026 GenericEnhancedY
Trademark Usage Guidelines. Licensee shall use the Licensed Trademarks only in the form and manner approved by the Licensor and in compliance with the Trademark Usage Guidelines set forth in Exhibit [X] attached hereto. The Licensed Trademarks shall be displayed with appropriate trademark notices (™ or ®) as directed by Licensor. Licensee shall not: (a) alter, modify, distort, or misrepresent the Licensed Trademarks in any way, including changing the color, proportions, elements, or orientation; (b) use the Licensed Trademarks in a manner that could tarnish, dilute, or bring into disrepute the reputation or goodwill associated with the Licensed Trademarks; (c) use the Licensed Trademarks as part of Licensee's own trade name, corporate name, domain name, or social media handle without prior written approval; (d) register or attempt to register any trademark, service mark, or domain name that is confusingly similar to any Licensed Trademark; or (e) contest or challenge the validity of the Licensed Trademarks or Licensor's ownership thereof. All goodwill arising from the use of the Licensed Trademarks by Licensee shall inure exclusively to the benefit of the Licensor. Licensor reserves the right to review and approve all uses of the Licensed Trademarks and to revoke approval at any time if usage does not conform to these guidelines.
Open Source License Compliance
02/26/2026 GenericEnhancedY
Open Source License Compliance. The Contractor shall maintain a comprehensive inventory of all open source software components incorporated into or distributed with the Deliverables, including the name, version, and applicable license for each component. The Contractor represents and warrants that: (a) all open source components used in the Deliverables are identified in the Software Bill of Materials (SBOM) provided to the Client; (b) all open source components are used in compliance with their respective license terms; (c) no open source component is incorporated in a manner that would require the Client's proprietary software to be disclosed or distributed under an open source license (including any "copyleft" or "viral" license obligation such as GPL, LGPL, or AGPL) unless expressly approved in writing by the Client in advance; (d) the Contractor has conducted due diligence, including automated scanning with commercially available tools, to identify all open source components and their license obligations; and (e) the Contractor shall promptly notify the Client of any newly discovered open source components or license obligations. The Contractor shall indemnify the Client against any claims arising from the Contractor's failure to comply with open source license obligations.
Code of Business Conduct
02/26/2026 GenericEnhancedY
Code of Business Conduct and Ethics. All directors, officers, employees, and agents of the Company are expected to act honestly, ethically, and in the best interests of the Company at all times. This Code of Business Conduct and Ethics establishes the standards of behavior and the ethical principles by which the Company conducts its business. Each individual shall: (a) comply with all applicable laws, rules, and regulations in the performance of their duties; (b) avoid conflicts of interest between personal and professional relationships and promptly disclose any material transaction or relationship that could give rise to such a conflict; (c) maintain the confidentiality of all proprietary and confidential information; (d) protect and properly use Company assets and resources; (e) compete fairly and ethically and comply with all applicable antitrust and competition laws; (f) not offer, give, solicit, or receive any form of bribe, kickback, or improper payment to or from any person, including government officials, in accordance with the Foreign Corrupt Practices Act (FCPA) and the UK Bribery Act; (g) maintain accurate and complete books, records, and financial statements; and (h) report any known or suspected violations of this Code, applicable law, or Company policy through the Company's designated reporting channels. Violations of this Code may result in disciplinary action, up to and including termination of employment and referral for criminal prosecution.
Conflict of Interest Policy
02/26/2026 GenericEnhancedY
Conflict of Interest Policy. A conflict of interest arises when a director, officer, or employee's personal, financial, or other interests interfere or appear to interfere with the interests of the Company. All individuals covered by this policy have a duty to avoid conflicts of interest and to disclose any situation that may involve an actual or potential conflict. A conflict of interest may exist when: (a) an individual or a member of their immediate family has a financial interest in, or receives compensation or benefits from, an entity that does business with or competes with the Company; (b) an individual or a member of their immediate family serves as an officer, director, partner, employee, or consultant of an entity that does business with or competes with the Company; (c) an individual has the opportunity to take advantage of corporate information, property, or opportunities for personal gain; or (d) an individual uses Company resources, including time, equipment, or information, for personal benefit. All potential or actual conflicts of interest must be disclosed in writing to the Compliance Officer or the Board of Directors' Audit Committee. The Audit Committee shall review each disclosure and determine the appropriate course of action, which may include requiring the interested party to recuse themselves from any related decision-making process.
Record Retention Policy
02/26/2026 GenericEnhancedY
Record Retention Policy. The Company shall maintain a comprehensive record retention program that governs the creation, maintenance, protection, retrieval, and destruction of all Company records in compliance with applicable laws and regulations, including the Sarbanes-Oxley Act, SEC regulations, IRS requirements, HIPAA (where applicable), and state record retention statutes. Records shall be classified into categories with specific retention periods as follows: (a) corporate records (articles of incorporation, bylaws, minutes, stock records) — permanent; (b) financial records (general ledger, audited financial statements, tax returns) — minimum seven (7) years; (c) employment records (personnel files, payroll records, I-9 forms) — as required by applicable federal and state law, generally three (3) to seven (7) years after termination; (d) contracts and legal documents — duration of the agreement plus seven (7) years; (e) insurance records — life of the policy plus seven (7) years; and (f) electronic communications — three (3) years unless subject to a litigation hold. No records shall be destroyed if they are subject to a pending or reasonably foreseeable litigation, audit, investigation, or regulatory proceeding. The intentional destruction of records in violation of a litigation hold or regulatory preservation requirement is strictly prohibited and may constitute a criminal offense.
Insider Trading Policy
02/26/2026 GenericEnhancedY
Insider Trading Policy. Federal securities laws, including the Securities Exchange Act of 1934, prohibit the purchase or sale of securities by any person who is in possession of material, nonpublic information (MNPI) about the issuer of such securities. It is the policy of the Company that no director, officer, employee, or any other person who has access to MNPI about the Company or any other company with which the Company has a business relationship shall: (a) buy, sell, gift, or otherwise trade in the securities of the Company (or such other company) while in possession of MNPI; (b) communicate ("tip") MNPI to any other person who may trade on the basis of that information; or (c) recommend the purchase or sale of securities on the basis of MNPI. For purposes of this policy, "material" information is any information that a reasonable investor would consider important in deciding whether to buy, sell, or hold a security, including but not limited to: financial results, earnings forecasts, mergers and acquisitions, significant contracts, changes in senior management, FDA approvals or denials, and material litigation. All covered persons are subject to a trading blackout period beginning fourteen (14) days before the end of each fiscal quarter and ending two (2) full business days after the public release of quarterly or annual financial results. Pre-clearance from the General Counsel is required for all trades by directors, officers, and other designated insiders.
Anti-Bribery & Anti-Corruption Policy
02/26/2026 GenericEnhancedY
Anti-Bribery and Anti-Corruption Policy. The Company has zero tolerance for bribery and corruption in any form and is committed to full compliance with the United States Foreign Corrupt Practices Act (FCPA), the UK Bribery Act 2010, and all other applicable anti-bribery and anti-corruption laws. No director, officer, employee, agent, or representative of the Company shall, directly or indirectly: (a) offer, promise, authorize, give, or pay any bribe, kickback, or other improper payment or benefit to any person, including any government official, political party, party official, or candidate for political office, for the purpose of obtaining or retaining business or securing any improper advantage; (b) request, agree to receive, or accept any bribe or improper payment or benefit; or (c) make any facilitating or "grease" payment to any government official to expedite or secure the performance of a routine governmental action. All gifts, entertainment, hospitality, charitable donations, sponsorships, and political contributions must comply with the Company's Gift and Entertainment Policy and must be pre-approved where required. The Company shall maintain accurate books and records that fairly reflect all transactions and dispositions of assets. Third-party due diligence shall be conducted on all agents, intermediaries, consultants, and joint venture partners prior to engagement.
Change Order Procedures
02/26/2026 GenericEnhancedY
Change Order Procedures. No changes to the Contract Documents, scope of work, contract price, or contract time shall be made except by a written Change Order signed by both the Owner and the Contractor (or a Construction Change Directive issued by the Owner). All proposed changes shall be submitted in writing and shall include: (a) a detailed description of the proposed change and the reason for the change; (b) the effect on the contract price, including an itemized breakdown of all labor, materials, equipment, subcontractor costs, overhead, and profit; (c) the effect on the contract time, including a revised schedule showing the impact on the critical path; and (d) any effect on existing warranties or guarantees. The Contractor shall submit a Change Order proposal within fourteen (14) days of receipt of a written request from the Owner or Architect. The Owner shall approve or reject the Change Order proposal within fourteen (14) days of receipt. The Contractor shall not proceed with any changed work until a Change Order has been executed or a Construction Change Directive has been issued. If the Parties cannot agree on the price adjustment, the Owner may direct the Contractor to proceed on a time-and-materials basis, and the final cost shall be determined in accordance with the contract's dispute resolution provisions.
Liquidated Damages
02/26/2026 GenericEnhancedY
Liquidated Damages. The Parties acknowledge that the Owner will suffer financial harm if the Work is not completed by the date of Substantial Completion as specified in the Contract Documents, and that such harm would be difficult or impossible to ascertain with certainty. Therefore, the Contractor shall pay to the Owner, as liquidated damages and not as a penalty, the sum of [$ amount] per calendar day for each day that the Work remains incomplete beyond the date of Substantial Completion as adjusted by any approved Change Orders or extensions of time. The total amount of liquidated damages under this provision shall not exceed [$ amount or percentage of contract price]. The Owner may deduct liquidated damages from any payments due or to become due to the Contractor. The Contractor shall not be liable for liquidated damages for delays caused by: (a) acts or omissions of the Owner; (b) changes in the work ordered by the Owner; (c) Force Majeure events as defined elsewhere in this Agreement; (d) unusually severe weather conditions not reasonably anticipated; or (e) any other cause beyond the Contractor's reasonable control, provided the Contractor has given timely written notice and documentation of the delay to the Owner. The assessment of liquidated damages shall be the Owner's sole and exclusive remedy for delay.
Performance Bond Requirements
02/26/2026 GenericEnhancedY
Performance Bond Requirements. Prior to the commencement of work, the Contractor shall furnish to the Owner a Performance Bond in the amount of one hundred percent (100%) of the Contract Price, and a Payment Bond in the amount of one hundred percent (100%) of the Contract Price, both issued by a surety company authorized to do business in the state where the project is located and acceptable to the Owner. The bonds shall be in the form prescribed by the Contract Documents and shall comply with all applicable statutory requirements, including the Miller Act (40 U.S.C. §§ 3131-3134) for federal projects, or applicable state Little Miller Act provisions for state and local public projects. The Performance Bond shall guarantee the faithful performance of the Contract and the prompt and proper completion of all work in accordance with the Contract Documents. The Payment Bond shall guarantee payment of all obligations arising under the Contract, including payment to all subcontractors, laborers, and material suppliers. The surety company shall have a current A.M. Best rating of A- or better and a financial size category of VII or higher. If the surety company becomes unacceptable to the Owner at any time during the performance of the Contract, the Contractor shall promptly provide replacement bonds from an acceptable surety at no additional cost to the Owner.
Safety & OSHA Compliance
02/26/2026 GenericEnhancedY
Safety and OSHA Compliance. The Contractor shall be solely responsible for initiating, maintaining, and supervising all safety precautions and programs in connection with the performance of the Work, and shall comply with all applicable safety and health laws, regulations, and standards, including the Occupational Safety and Health Act (OSHA), 29 CFR Part 1926 (Safety and Health Regulations for Construction), and all applicable state and local safety codes. The Contractor shall: (a) designate a competent person as the Site Safety Officer who shall be responsible for the implementation and enforcement of the safety program; (b) develop and maintain a written site-specific safety plan, including a hazard communication program, fall protection plan, confined space entry procedures, excavation safety plan, and emergency action plan; (c) conduct daily safety inspections and weekly toolbox talks; (d) provide all required personal protective equipment (PPE) to workers at no cost; (e) report all accidents, injuries, near-misses, and OSHA-recordable incidents to the Owner within twenty-four (24) hours; (f) maintain OSHA 300 logs and make them available upon request; and (g) cooperate fully with any OSHA inspections or investigations. The Owner reserves the right to stop work if, in the Owner's reasonable judgment, unsafe conditions exist.
Mechanic's Lien Waiver
02/26/2026 GenericEnhancedY
Mechanic's Lien Waiver. Upon receipt of each progress payment, the Contractor shall provide to the Owner a Conditional Waiver and Release on Progress Payment for the amount of the current payment application, and an Unconditional Waiver and Release on Progress Payment for the amount of the previous payment received. Upon receipt of final payment, the Contractor shall provide an Unconditional Waiver and Release on Final Payment. The Contractor shall also obtain and deliver to the Owner corresponding lien waivers from all subcontractors and material suppliers for each payment period. The lien waivers shall be in the form prescribed by applicable state law, or if no statutory form exists, in the form attached hereto as Exhibit [X]. The Owner shall have the right to withhold payment if the Contractor fails to provide the required lien waivers. The Contractor shall indemnify and hold harmless the Owner from and against any and all mechanic's liens, stop notices, or bond claims filed against the Owner or the property as a result of the Contractor's failure to pay its subcontractors, laborers, or material suppliers. The Contractor shall promptly cause any such lien to be released or bonded within ten (10) business days of written notice from the Owner.
Service Level Agreement (SLA)
02/26/2026 GenericEnhancedY
Service Level Agreement. The Provider shall use commercially reasonable efforts to make the Service available with a Monthly Uptime Percentage of at least 99.9% during each calendar month (the "Uptime Commitment"). "Monthly Uptime Percentage" is calculated as: ((Total Minutes in Month - Downtime Minutes) / Total Minutes in Month) × 100. "Downtime" means any period during which the Service is unavailable, excluding Scheduled Maintenance and any unavailability caused by circumstances beyond the Provider's reasonable control. Scheduled Maintenance shall be performed during the maintenance windows specified in the Service Description and with at least seventy-two (72) hours' advance notice. If the Provider fails to meet the Uptime Commitment in any calendar month, the Customer shall be eligible for Service Credits as follows: 99.0% to 99.9% — 10% credit of monthly fees; 95.0% to 98.9% — 25% credit of monthly fees; below 95.0% — 50% credit of monthly fees. Service Credits are the Customer's sole and exclusive remedy for any failure to meet the Uptime Commitment. Customer must request Service Credits within thirty (30) days of the incident. Service Credits shall not exceed 50% of the monthly fees for the affected month and may not be exchanged for cash.
Acceptable Use Policy
02/26/2026 GenericEnhancedY
Acceptable Use Policy. Customer agrees not to use the Service, and shall not permit any third party to use the Service, for any purpose that is illegal, harmful, or otherwise prohibited by this Acceptable Use Policy. Specifically, Customer shall not: (a) use the Service to transmit, distribute, or store material that violates any applicable law, regulation, or third-party right, including material that is defamatory, obscene, threatening, or that infringes intellectual property rights; (b) use the Service to distribute viruses, worms, Trojan horses, corrupted files, or any other similar software or programs designed to damage or alter a computer system or data; (c) interfere with, disrupt, or create an undue burden on the Service or the networks or services connected to the Service, including through denial-of-service attacks, brute-force attacks, or data scraping; (d) attempt to gain unauthorized access to the Service, other accounts, computer systems, or networks connected to the Service; (e) use the Service for cryptocurrency mining or other computationally intensive operations not authorized by the Provider; (f) resell, sublicense, or make the Service available to third parties without the Provider's prior written consent; or (g) use the Service in any manner that violates applicable export control or sanctions laws. Provider reserves the right to suspend or terminate Customer's access to the Service for violation of this Acceptable Use Policy, with or without notice.
Data Security Standards
02/26/2026 GenericEnhancedY
Data Security Standards. The Provider shall implement and maintain administrative, technical, and physical safeguards designed to protect Customer Data against unauthorized access, use, disclosure, alteration, or destruction, in accordance with industry best practices and applicable law. Security measures shall include, at a minimum: (a) encryption of Customer Data in transit using TLS 1.2 or higher and at rest using AES-256 or equivalent; (b) multi-factor authentication (MFA) for all administrative access to systems processing Customer Data; (c) role-based access controls (RBAC) implementing the principle of least privilege; (d) continuous monitoring and logging of all access to systems containing Customer Data, with logs retained for a minimum of twelve (12) months; (e) regular vulnerability assessments and annual penetration testing conducted by a qualified independent third party, with remediation of critical and high-severity findings within thirty (30) days; (f) an incident response plan that includes procedures for detection, containment, investigation, remediation, and notification; (g) employee security awareness training at least annually; and (h) maintenance of SOC 2 Type II certification (or equivalent) covering the Security, Availability, and Confidentiality trust service criteria. Upon Customer's written request, the Provider shall provide copies of its most recent SOC 2 report and penetration test executive summary.
Disaster Recovery & Business Continuity
02/26/2026 GenericEnhancedY
Disaster Recovery and Business Continuity. The Provider shall maintain a documented disaster recovery and business continuity plan (DR/BCP) that ensures the continuity of the Service and the protection of Customer Data in the event of a disaster, system failure, or other disruptive event. The DR/BCP shall include, at a minimum: (a) a Recovery Time Objective (RTO) of [X hours], meaning the Service shall be restored within [X hours] of a declared disaster; (b) a Recovery Point Objective (RPO) of [X hours], meaning Customer Data shall be recoverable to a point no more than [X hours] prior to the disaster; (c) geographically separated backup and recovery infrastructure that is not susceptible to the same risk events as the primary infrastructure; (d) automated daily backups of all Customer Data, with backups verified through regular restore testing at least quarterly; (e) an annual DR test simulating a full failover to the recovery environment, with results documented and shared with Customer upon request; (f) a communication plan that provides Customer with notification within one (1) hour of a declared disaster and regular status updates until service restoration; and (g) a post-incident review process that identifies root causes and implements corrective actions to prevent recurrence.
Software Warranty & Disclaimer
02/26/2026 GenericEnhancedY
Software Warranty and Disclaimer. The Provider warrants that the Software shall perform materially in accordance with the Documentation for a period of ninety (90) days from the date of delivery or initial access (the "Warranty Period"). If the Software fails to conform to this warranty during the Warranty Period, the Customer's sole and exclusive remedy, and the Provider's entire liability, shall be for the Provider to use commercially reasonable efforts to correct the nonconformity, or, if the Provider is unable to correct the nonconformity within thirty (30) days, to refund the license fees paid for the nonconforming Software. EXCEPT FOR THE EXPRESS WARRANTY SET FORTH ABOVE, THE PROVIDER PROVIDES THE SOFTWARE AND SERVICES "AS IS" AND "AS AVAILABLE" WITHOUT WARRANTY OF ANY KIND, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHERWISE. THE PROVIDER SPECIFICALLY DISCLAIMS ALL IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, AND NON-INFRINGEMENT, AND ALL WARRANTIES ARISING FROM COURSE OF DEALING, USAGE, OR TRADE PRACTICE. THE PROVIDER DOES NOT WARRANT THAT THE SOFTWARE WILL BE UNINTERRUPTED, ERROR-FREE, OR FREE OF HARMFUL COMPONENTS, OR THAT ANY DATA WILL BE SECURE OR NOT OTHERWISE LOST OR DAMAGED.
FERPA Student Privacy
02/26/2026 GenericEnhancedY
FERPA Student Privacy Notice. In accordance with the Family Educational Rights and Privacy Act (FERPA), 20 U.S.C. § 1232g, and its implementing regulations at 34 CFR Part 99, this institution protects the privacy of student education records. Students have the right to: (a) inspect and review their education records within forty-five (45) days of submitting a written request; (b) request the amendment of education records that the student believes are inaccurate, misleading, or otherwise in violation of their privacy rights; (c) consent to disclosures of personally identifiable information contained in the student's education records, except to the extent that FERPA authorizes disclosure without consent; and (d) file a complaint with the U.S. Department of Education concerning alleged failures by the institution to comply with FERPA. The institution may disclose education records without consent to: school officials with legitimate educational interests; other schools to which a student is transferring; specified officials for audit or evaluation purposes; appropriate parties in connection with financial aid; organizations conducting certain studies for or on behalf of the school; accrediting organizations; and in compliance with a judicial order or lawfully issued subpoena. The institution has designated the following as "directory information" that may be disclosed without consent: student name, address, telephone number, email address, date and place of birth, major fie...
Title IX Non-Discrimination
02/26/2026 GenericEnhancedY
Title IX Non-Discrimination Statement. In accordance with Title IX of the Education Amendments of 1972, 20 U.S.C. § 1681 et seq., and its implementing regulations at 34 CFR Part 106, this institution does not discriminate on the basis of sex in any education program or activity that it operates, including admissions, employment, and financial assistance. Sex-based discrimination includes sexual harassment, sexual violence, dating violence, domestic violence, stalking, and other forms of sex- or gender-based harassment, discrimination, or retaliation. The institution has designated a Title IX Coordinator who is responsible for coordinating the institution's compliance with Title IX and receiving inquiries and complaints. Any person may report sex discrimination, including sexual harassment, to the Title IX Coordinator at any time, including during non-business hours, by telephone, email, mail, or in person. Upon receipt of a formal complaint, the institution will conduct a prompt, thorough, and impartial investigation in accordance with its grievance procedures. Both the complainant and the respondent shall be afforded equal rights throughout the process, including the right to an advisor of their choice, equal access to evidence, and written notice of the outcome. Retaliation against any person for reporting, participating, or refusing to participate in any proceeding under this policy is strictly prohibited.
Academic Integrity Policy
02/26/2026 GenericEnhancedY
Academic Integrity Policy. The institution is committed to the highest standards of academic integrity and expects all students, faculty, and staff to uphold these principles in all academic work. Academic dishonesty includes, but is not limited to: (a) plagiarism, defined as the submission of another's work, words, or ideas as one's own without proper attribution, including material from published and unpublished sources, the internet, and artificial intelligence-generated content; (b) cheating, including the use of unauthorized materials, devices, or assistance during examinations or in the completion of assignments; (c) fabrication, including the falsification or invention of data, citations, or other information in academic work; (d) facilitating dishonesty, including knowingly helping or attempting to help another person commit an act of academic dishonesty; (e) multiple submissions, including submitting the same work in more than one course without prior authorization; and (f) sabotage, including the deliberate destruction or interference with another student's work. Violations of this policy may result in sanctions including, but not limited to: a failing grade on the assignment, a failing grade in the course, academic probation, suspension, or expulsion. Students have the right to appeal academic integrity findings through the institution's established appeals process.
Disability Accommodations (Section 504)
02/26/2026 GenericEnhancedY
Disability Accommodations. In accordance with Section 504 of the Rehabilitation Act of 1973 (29 U.S.C. § 794) and the Americans with Disabilities Act of 1990 (42 U.S.C. § 12101 et seq.), this institution is committed to providing equal access and reasonable accommodations to qualified students with disabilities. A qualified student with a disability is a student who, with or without reasonable accommodations, meets the academic and technical standards requisite for admission to and participation in the institution's programs and activities. Students requesting accommodations must: (a) self-identify to the Office of Disability Services; (b) provide current documentation of the disability from a qualified professional, including the diagnosis, the functional limitations, and the recommended accommodations; and (c) participate in an interactive process with the Disability Services Coordinator to determine appropriate and reasonable accommodations. Accommodations may include, but are not limited to: extended time on examinations, alternative test formats, note-taking services, assistive technology, accessible housing, sign language interpreting, and priority course registration. The institution is not required to provide accommodations that would fundamentally alter the nature of a program, create an undue financial or administrative burden, or pose a direct threat to the health or safety of others. Students who believe they have been denied reasonable accommodations may file ...
Donor Privacy Policy
02/26/2026 GenericEnhancedY
Donor Privacy Policy. This organization is committed to protecting the privacy of its donors and respects the confidentiality of all donor information. This policy applies to all donor information collected by the organization, whether online or offline. The organization shall: (a) not sell, share, trade, or rent donor personal information, including names, addresses, email addresses, phone numbers, and financial information, to any third party, except as required by law or with the donor's express written consent; (b) use donor information solely for the purposes of processing donations, providing tax receipts, communicating about the organization's programs and events, and fulfilling the organization's mission; (c) implement appropriate security measures to protect donor information from unauthorized access, use, or disclosure; (d) honor requests from donors to remain anonymous in all public acknowledgments, publications, and donor recognition listings; (e) honor requests from donors to limit the frequency or type of communications they receive; and (f) provide donors with access to their personal information upon request and the ability to update or correct inaccurate information. This policy is reviewed annually by the Board of Directors and updated as necessary to reflect changes in law, technology, or organizational practices.
Gift Acceptance Policy
02/26/2026 GenericEnhancedY
Gift Acceptance Policy. This organization solicits and accepts gifts that are consistent with its mission, purposes, and priorities. The Board of Directors or its designee shall have the authority to accept or decline any gift in the best interests of the organization. The following types of gifts are generally accepted without review: (a) cash, checks, and credit card contributions; (b) publicly traded securities; (c) bequests and beneficiary designations under revocable wills, trusts, and retirement plans; and (d) charitable gift annuities meeting the organization's minimum funding requirements. The following types of gifts require review and approval by the Gift Acceptance Committee prior to acceptance: (e) real property, including gifts subject to environmental liabilities; (f) closely held or restricted securities; (g) tangible personal property; (h) in-kind gifts and services; (i) life insurance policies; and (j) gifts involving a retained life estate. The organization will not accept gifts that: (i) would result in a violation of the organization's charter, bylaws, or applicable law; (ii) would jeopardize the organization's tax-exempt status; (iii) are too difficult or costly to administer in relation to their value; or (iv) involve unlawful discrimination of any kind. All donors are encouraged to seek independent legal and tax advice before making significant gifts. Gift acknowledgments and tax receipts shall be issued in compliance with IRS requirements under Sect...
Conflict of Interest (Nonprofit)
02/26/2026 GenericEnhancedY
Conflict of Interest Policy for Nonprofit Organizations. The purpose of this Conflict of Interest Policy is to protect the organization's interest when it is contemplating entering into a transaction or arrangement that might benefit the private interest of an officer, director, or key employee of the organization, or might result in a possible excess benefit transaction as defined by Section 4958 of the Internal Revenue Code. Any director, officer, or member of a committee with Board-delegated powers who has a direct or indirect financial interest in a proposed transaction or arrangement shall: (a) disclose the existence of the financial interest and all material facts related thereto to the Board of Directors or relevant committee; (b) recuse themselves from the discussion and vote on the transaction or arrangement; and (c) not attempt to influence improperly the deliberation or voting on the matter. After disclosure of the financial interest, the remaining disinterested Board or committee members shall determine whether the organization can obtain, with reasonable efforts, a more advantageous transaction or arrangement from a person or entity that would not give rise to a conflict of interest. If a more advantageous transaction or arrangement is not reasonably possible, the Board or committee shall determine by a majority vote of the disinterested members whether the transaction or arrangement is in the organization's best interest, for its own benefit, and whether it i...
Charitable Solicitation Disclosure
02/26/2026 GenericEnhancedY
Charitable Solicitation Disclosure. In accordance with applicable state charitable solicitation registration laws, the following disclosures are made: This organization is a tax-exempt nonprofit organization under Section 501(c)(3) of the Internal Revenue Code, and donations are tax-deductible to the extent permitted by law. A copy of the organization's latest annual report and financial statements may be obtained by contacting the organization at [Address]. Registration with a state agency does not constitute or imply endorsement, approval, or recommendation by that state. Certain states require the following specific disclosures: Florida — A COPY OF THE OFFICIAL REGISTRATION AND FINANCIAL INFORMATION MAY BE OBTAINED FROM THE DIVISION OF CONSUMER SERVICES BY CALLING TOLL-FREE (800-435-7352) WITHIN THE STATE. REGISTRATION DOES NOT IMPLY ENDORSEMENT, APPROVAL, OR RECOMMENDATION BY THE STATE. Registration No. [XX]. New York — A copy of the organization's latest annual report may be obtained from the organization or from the New York Attorney General's Charities Bureau. Virginia — A financial statement is available from the State Division of Consumer Affairs in the Department of Agriculture and Consumer Services upon request. The organization is registered or has filed for registration in all states in which registration is required under applicable charitable solicitation laws.
Environmental Impact Assessment
02/26/2026 GenericEnhancedY
Environmental Impact Assessment. Prior to the commencement of the proposed project or activity, an Environmental Impact Assessment (EIA) shall be conducted in accordance with the National Environmental Policy Act (NEPA), 42 U.S.C. §§ 4321-4347, and its implementing regulations at 40 CFR Parts 1500-1508, or applicable state environmental review requirements. The EIA shall evaluate the direct, indirect, and cumulative environmental impacts of the proposed action, including but not limited to: (a) air quality impacts, including emissions of criteria pollutants and greenhouse gases; (b) water quality and water resource impacts, including effects on surface water, groundwater, wetlands, and floodplains; (c) impacts on soil, geology, and land use; (d) impacts on biological resources, including threatened and endangered species and critical habitat; (e) noise and vibration impacts; (f) traffic and transportation impacts; (g) impacts on cultural and historical resources; (h) socioeconomic impacts, including environmental justice considerations; and (i) cumulative effects when considered in conjunction with other past, present, and reasonably foreseeable future actions. The EIA shall also evaluate reasonable alternatives to the proposed action, including a no-action alternative, and shall identify all feasible mitigation measures. Public participation opportunities shall be provided as required by applicable law.
Hazardous Waste Management
02/26/2026 GenericEnhancedY
Hazardous Waste Management. All hazardous waste generated, stored, treated, transported, or disposed of in connection with this facility or project shall be managed in compliance with the Resource Conservation and Recovery Act (RCRA), 42 U.S.C. §§ 6901-6992k, and its implementing regulations at 40 CFR Parts 260-270, as well as all applicable state hazardous waste regulations. The responsible party shall: (a) make a hazardous waste determination for each waste stream in accordance with 40 CFR Part 262.11; (b) obtain and maintain an EPA Identification Number from the appropriate regulatory authority; (c) comply with all applicable generator requirements based on generator status (Large Quantity Generator, Small Quantity Generator, or Very Small Quantity Generator); (d) ensure that all hazardous waste is properly labeled, containerized, and stored in compliance with applicable regulations, including secondary containment and maximum accumulation time limits; (e) prepare hazardous waste manifests for all off-site shipments using EPA Form 8700-22; (f) use only licensed and permitted transporters and treatment, storage, and disposal facilities (TSDFs); (g) maintain all hazardous waste records, including manifests, for a minimum of three (3) years; and (h) conduct hazardous waste training for all personnel who manage hazardous waste, at minimum annually.
Spill Prevention & Response
02/26/2026 GenericEnhancedY
Spill Prevention and Response Plan. This Spill Prevention, Control, and Countermeasure (SPCC) Plan is prepared in accordance with 40 CFR Part 112 and applicable state regulations to prevent discharges of oil and hazardous substances into navigable waters of the United States. The Plan includes: (a) an identification and description of all oil and hazardous substance storage containers, tanks, and equipment, including capacities, contents, and secondary containment measures; (b) a facility diagram showing the location of all storage areas, drainage patterns, watercourses, and spill response equipment; (c) an analysis of the potential for spills and a determination of the maximum quantity that could be released from each container; (d) spill prevention measures, including secondary containment designed to hold the contents of the largest container plus sufficient freeboard for precipitation; (e) inspection and maintenance schedules for all storage equipment and containment systems; (f) spill response procedures, including immediate actions to contain and clean up released materials, notification procedures for reaching emergency response personnel, and reporting requirements to federal, state, and local agencies as required by law; (g) designated spill response equipment locations and inventory; and (h) annual spill prevention training for all facility personnel. This Plan shall be reviewed and updated at least every five (5) years, or whenever there is a material change in ...
Air Quality Permits & Emissions
02/26/2026 GenericEnhancedY
Air Quality Permits and Emissions Compliance. The facility shall comply with all applicable air quality requirements established under the Clean Air Act (CAA), 42 U.S.C. §§ 7401-7671q, including the National Ambient Air Quality Standards (NAAQS), New Source Performance Standards (NSPS) under 40 CFR Part 60, National Emission Standards for Hazardous Air Pollutants (NESHAP) under 40 CFR Parts 61 and 63, and all applicable state and local air quality regulations. The facility shall: (a) obtain and maintain all required air quality permits, including Title V Operating Permits, Prevention of Significant Deterioration (PSD) permits, or Nonattainment New Source Review (NNSR) permits, as applicable; (b) comply with all emission limitations, operational requirements, and monitoring, recordkeeping, and reporting conditions specified in each permit; (c) install, calibrate, and maintain all required continuous emissions monitoring systems (CEMS) and other monitoring equipment; (d) submit all required compliance reports, emissions inventories, and excess emissions reports within the deadlines established by the permit and applicable regulations; (e) conduct all required stack testing and periodic monitoring; and (f) maintain records of all air quality compliance activities for a minimum of five (5) years. Any exceedances of permitted emission limits shall be reported to the applicable regulatory authority within the timeframe specified by the permit, and corrective actions shall be doc...
System Validation — §11.10(a)
02/26/2026 GenericEnhancedY
System Validation Requirements. All computerized systems that create, modify, maintain, archive, retrieve, or transmit electronic records subject to 21 CFR Part 11 shall be validated to ensure accuracy, reliability, consistent intended performance, and the ability to discern invalid or altered records, in accordance with §11.10(a). The validation program shall follow a risk-based lifecycle approach and shall include: (a) a Validation Master Plan (VMP) that defines the scope, strategy, responsibilities, and schedule for all system validation activities; (b) a User Requirements Specification (URS) documenting the intended use, functional requirements, and regulatory requirements of the system; (c) a Functional Specification (FS) and Design Specification (DS) documenting how the system will meet the requirements; (d) Installation Qualification (IQ) verifying that the system hardware, software, and infrastructure are installed correctly and in accordance with specifications; (e) Operational Qualification (OQ) verifying that the system operates correctly throughout all anticipated operating ranges; (f) Performance Qualification (PQ) verifying that the system consistently performs as intended under actual or simulated conditions of use; (g) traceability matrices linking each requirement to its corresponding test case and test result; and (h) a Validation Summary Report documenting all testing results, deviations, and the overall validation conclusion. Validation shall be maintai...
Copies of Records — §11.10(b)
02/26/2026 GenericEnhancedY
Copies of Electronic Records. The system shall be capable of generating accurate and complete copies of electronic records in both human-readable and electronic form suitable for inspection, review, and copying by the FDA, in accordance with §11.10(b). Human-readable copies shall include all relevant metadata, including the identity of the person who created, modified, or deleted the record, the date and time of such action, and any electronic signatures associated with the record. Electronic copies shall be provided in a format that preserves the content, meaning, and context of the original record, and that allows the FDA to inspect, review, and copy the records using commonly available software. The system shall support the export of electronic records in formats such as PDF, XML, CSV, or other formats agreed upon with the reviewing authority. Procedures shall be established to define the process for generating copies of records upon request, including the identification of authorized personnel, the timeframe for producing copies, and the verification that exported copies are accurate and complete. The ability to generate accurate copies shall be verified during system validation and re-verified after any system change that could affect record generation or export capabilities.
Record Protection and Retention — §11.10(c)
02/26/2026 GenericEnhancedY
Record Protection and Retention. Electronic records shall be protected to enable their accurate and ready retrieval throughout the entire records retention period established by applicable predicate rules and organizational policies, in accordance with §11.10(c). The organization shall implement the following safeguards: (a) electronic records shall be stored in a manner that prevents unauthorized alteration, deletion, or destruction throughout the retention period; (b) backup and recovery procedures shall be established and tested to ensure records can be restored in the event of system failure, data corruption, or disaster; (c) backup copies shall be stored in a geographically separate, secure location with environmental controls appropriate for the storage media; (d) backup integrity shall be verified through periodic restore testing, conducted at least annually; (e) when records are migrated from one system to another, or from one storage medium to another, the migration process shall be validated to ensure that the content, meaning, context, and integrity of the records are preserved; (f) a record retention schedule shall be maintained that identifies the retention period for each category of electronic record based on the applicable predicate rule requirements (e.g., 21 CFR 211.180 requires batch production records to be retained for at least one year after the expiration date of the batch); and (g) records shall not be destroyed before the expiration of the applicab...
Limiting System Access — §11.10(d)
02/26/2026 GenericEnhancedY
System Access Controls. Access to computerized systems containing electronic records subject to 21 CFR Part 11 shall be limited to authorized individuals in accordance with §11.10(d). The organization shall implement the following access control measures: (a) each individual who accesses the system shall be assigned a unique user account consisting of a user identification code and password, or other equivalent authentication mechanism; user accounts shall not be shared among individuals; (b) a formal access request and approval process shall be established requiring written authorization from the system owner or department management before access is granted; (c) access privileges shall be assigned based on the principle of least privilege, granting each user only the minimum level of access required to perform their job functions; (d) role-based access control (RBAC) shall be implemented to define and enforce access privileges based on organizational roles and responsibilities; (e) access privileges shall be reviewed at least every six (6) months by the system owner to verify that access remains appropriate and that terminated or transferred personnel have been promptly deactivated; (f) user accounts shall be automatically locked after a defined number of consecutive failed login attempts, not to exceed five (5); (g) inactive sessions shall be automatically locked or terminated after a defined period of inactivity, not to exceed fifteen (15) minutes; and (h) all access p...
Audit Trail — §11.10(e)
02/26/2026 GenericEnhancedY
Audit Trail Requirements. The system shall employ secure, computer-generated, time-stamped audit trails to independently record the date and time of operator entries and actions that create, modify, or delete electronic records, in accordance with §11.10(e). The audit trail shall meet the following requirements: (a) audit trail entries shall be automatically generated by the system and shall not be modifiable by any user, including system administrators; (b) each audit trail entry shall record, at a minimum: the identity of the person who performed the action (linked to their unique user identification), the date and time of the action (synchronized to a trusted and traceable time source), the type of action performed (create, modify, delete, approve, reject, etc.), the field or data element affected, the previous value (before change), and the new value (after change); (c) audit trail data shall be retained for a period at least as long as the electronic records to which it pertains, as required by the applicable predicate rule; (d) audit trail data shall be available for review and copying by the FDA upon request; (e) the audit trail shall be included as part of the record review process, and designated personnel shall periodically review audit trails for unauthorized changes, anomalies, or potential data integrity issues; (f) any attempts to alter, disable, or delete audit trail functionality shall be recorded and shall trigger an alert to the system administrator and t...
Operational System Checks — §11.10(f)
02/26/2026 GenericEnhancedY
Operational System Checks. The system shall employ operational system checks to enforce permitted sequencing of steps and events, as appropriate, in accordance with §11.10(f). Operational system checks are programmatic controls built into the system to ensure that processes are executed in the correct order and that required steps are not inadvertently or deliberately skipped. The following operational checks shall be implemented where applicable: (a) workflow enforcement mechanisms that ensure required process steps are completed in the prescribed sequence (e.g., a batch record cannot advance to the next production step until the current step has been completed and electronically signed); (b) system controls that prevent the entry of data outside of predefined ranges, formats, or value sets (e.g., input validation, field format checks, and reasonableness checks); (c) system controls that prevent the approval of records by the same individual who created or modified them, enforcing separation of duties where required by applicable predicate rules; (d) system controls that require the completion of all mandatory fields before a record can be saved or submitted; (e) system controls that enforce the completion of prerequisite activities before subsequent activities are initiated (e.g., equipment calibration must be current before use in testing); and (f) all operational system checks shall be documented in the system design specifications and verified during system validation...
Authority Checks — §11.10(g)
02/26/2026 GenericEnhancedY
Authority Checks. The system shall employ authority checks to ensure that only authorized individuals can use the system, electronically sign a record, access the operation or computer system input or output device, alter a record, or perform the operation at hand, in accordance with §11.10(g). Authority checks shall be implemented as follows: (a) the system shall verify, at the time of each critical action, that the individual performing the action has the appropriate privileges assigned to their user role; (b) electronic signature authority shall be restricted to individuals who have been formally designated as authorized signatories for the specific record type or process, as documented in the organization's signature authority matrix; (c) the system shall prevent unauthorized users from performing actions outside the scope of their assigned role, including creating, modifying, approving, rejecting, or deleting records; (d) elevated privileges (e.g., system administrator functions) shall be restricted to the minimum number of individuals necessary and shall require additional authentication where feasible; (e) the assignment and modification of authority levels shall be controlled through a documented process requiring management approval and shall be subject to periodic review; (f) any attempt by a user to perform an action for which they are not authorized shall be blocked by the system and logged in the audit trail; and (g) authority check configurations shall be doc...
Device Checks — §11.10(h)
02/26/2026 GenericEnhancedY
Device Checks. The system shall employ device checks, as appropriate, to determine the validity of the source of data input or operational instruction, in accordance with §11.10(h). Device checks are controls designed to verify that data originates from an authorized and properly functioning source, particularly when data is automatically captured from instruments, equipment, or external systems. The following device checks shall be implemented where applicable: (a) verification of the identity and status of connected instruments, equipment, or devices prior to accepting data input (e.g., confirming that a laboratory instrument is within its calibration validity period before accepting test results); (b) validation of communication protocols and data integrity checks (e.g., checksums, cyclic redundancy checks, or digital signatures) for data transmitted between systems or devices; (c) verification that the data format, range, and type received from a device are consistent with expected values, and rejection or flagging of data that falls outside acceptable parameters; (d) authentication of the source system or device when receiving data from external or networked sources; (e) logging of all device-generated data inputs, including the device identifier, timestamp, and the identity of the operator (if applicable); and (f) all device check configurations and their effectiveness shall be verified during system validation and documented in the validation package.
Personnel Training — §11.10(i)
02/26/2026 GenericEnhancedY
Personnel Training and Qualification. All individuals who develop, maintain, or use electronic record and electronic signature systems subject to 21 CFR Part 11 shall be trained and qualified to perform their assigned tasks, in accordance with §11.10(i). The training program shall include: (a) initial training for all new users prior to being granted system access, covering the specific system functionality relevant to their role, data integrity principles, electronic record and signature requirements, and the organization's Part 11 policies and procedures; (b) training on the regulatory requirements of 21 CFR Part 11, including the legal equivalence of electronic signatures to handwritten signatures, the prohibition against falsifying electronic records or signatures, and the consequences of violations; (c) role-specific training for system administrators covering security configuration, user account management, audit trail review, and system maintenance procedures; (d) training for IT personnel and developers on secure system design, validation requirements, and change control procedures applicable to Part 11 systems; (e) retraining whenever there are significant changes to the system, procedures, or regulatory requirements; (f) periodic refresher training at defined intervals, not to exceed two (2) years; and (g) documentation of all training activities, including the training date, subject matter, trainer identification, training method, and evidence of trainee compete...
Written Policies & Accountability — §11.10(j)
02/26/2026 GenericEnhancedY
Written Policies Holding Individuals Accountable. The organization shall establish and maintain written policies that hold individuals accountable and responsible for actions initiated under their electronic signatures, in order to deter record and signature falsification, in accordance with §11.10(j). These policies shall include: (a) a clear statement that electronic signatures are the legally binding equivalent of handwritten signatures and that signing an electronic record carries the same legal weight and accountability as signing a paper record; (b) a prohibition against the falsification, alteration, or misuse of electronic records and electronic signatures, and a statement that such actions may constitute violations of federal law subject to criminal penalties under 18 U.S.C. § 1001 and other applicable statutes; (c) a prohibition against sharing, lending, or allowing another individual to use one's electronic signature credentials (user identification code and password or other authentication mechanism); (d) a requirement that each individual safeguard their electronic signature credentials and immediately report any suspected compromise to the system administrator and the Quality Unit; (e) a description of the disciplinary actions that may be imposed for violations of these policies, up to and including termination of employment and referral for criminal prosecution; (f) a requirement that each individual who uses electronic signatures sign a written acknowledgme...
Documentation & Change Controls — §11.10(k)
02/26/2026 GenericEnhancedY
Documentation Controls and Change Management. Adequate controls shall be maintained over systems documentation, including distribution, access, and use of documentation for system operation and maintenance, in accordance with §11.10(k)(1); and revision and change control procedures shall be maintained to ensure an audit trail that documents time-sequenced development and modification of systems documentation, in accordance with §11.10(k)(2). The organization shall implement the following: (a) all system documentation, including requirements specifications, design documents, validation protocols, standard operating procedures (SOPs), configuration settings, and system administration guides, shall be maintained under formal document control; (b) system documentation shall be reviewed and approved by qualified personnel before being issued for use; (c) access to system documentation shall be controlled to prevent unauthorized modification; (d) a change control process shall be established that requires all changes to Part 11 systems to be formally requested, documented, assessed for impact on the validated state and regulatory compliance, approved by appropriate stakeholders (including the Quality Unit), tested, and verified before implementation; (e) the change control record shall include the description of the change, the reason for the change, the risk and impact assessment, the testing and validation performed, the approval signatures, and the implementation date; (f) em...
Open System Controls — §11.30
02/26/2026 GenericEnhancedY
Controls for Open Systems. Where electronic records are created, modified, maintained, or transmitted using open systems (i.e., systems in which system access is not controlled by persons responsible for the content of the electronic records), the organization shall employ additional measures designed to ensure the authenticity, integrity, and confidentiality of such records from the point of their creation to the point of their receipt, in accordance with §11.30. In addition to all controls required for closed systems under §11.10, open system controls shall include: (a) encryption of electronic records during transmission using industry-standard cryptographic protocols (e.g., TLS 1.2 or higher, AES-256 or equivalent) to protect against unauthorized interception, modification, or disclosure; (b) use of digital signatures conforming to an established standard (e.g., FIPS 186-4 or equivalent) to verify the identity of the sender and the integrity of the transmitted record; (c) implementation of message authentication codes (MACs) or hash functions to detect any alteration of records during transmission; (d) use of secure network architectures, including firewalls, intrusion detection/prevention systems, and virtual private networks (VPNs), to protect open system boundaries; (e) certificate-based authentication of all parties involved in the transmission of electronic records; and (f) documented procedures for the secure exchange of electronic records, including the verifica...
Signature Manifestations — §11.50
02/26/2026 GenericEnhancedY
Signature Manifestations. Electronic signatures and handwritten signatures executed to electronic records shall be linked to their respective electronic records to ensure that the signatures cannot be excised, copied, or otherwise transferred to falsify an electronic record by ordinary means, in accordance with §11.50. Each electronic signature applied to an electronic record shall include the following information displayed in human-readable form: (a) the printed name of the signer; (b) the date and time when the signature was executed; and (c) the meaning (such as review, approval, responsibility, verification, or authorship) associated with the signature. The signature meaning shall be clearly defined and consistently applied across all signed records. The elements of the signature manifestation (printed name, date/time, and meaning) shall be part of any human-readable display or printout of the signed electronic record. The system shall be configured to require the signer to select or confirm the signature meaning at the time of signing. Signature manifestation requirements shall be verified during system validation, and the accurate display of all signature elements shall be confirmed in both on-screen displays and printed or exported copies of signed records.
Signature/Record Linking — §11.70
02/26/2026 GenericEnhancedY
Signature and Record Linking. Electronic signatures and handwritten signatures executed to electronic records shall be linked to their respective electronic records to ensure that the signatures cannot be excised, copied, or otherwise transferred to falsify an electronic record by ordinary means, in accordance with §11.70. The system shall implement the following controls to ensure the integrity of the link between signatures and records: (a) electronic signatures shall be cryptographically bound to the specific version of the electronic record at the time of signing, such that any subsequent alteration to the signed record will invalidate or be detectably inconsistent with the signature; (b) the system shall prevent the removal, reapplication, or transfer of an electronic signature from one record to another; (c) the link between the electronic signature and the record shall be maintained throughout the records retention period and shall be verifiable upon retrieval; (d) where digital signature technology is used, the signing certificate, the hash of the signed record, and the encrypted signature value shall be stored as an integral part of the record; (e) the system shall include controls to prevent the backdating or post-dating of electronic signatures; and (f) the integrity of signature-record linking shall be verified during system validation, including testing scenarios that attempt to tamper with or transfer signatures between records. Any failure of signature-recor...
General E-Signature Requirements — §11.100
02/26/2026 GenericEnhancedY
General Requirements for Electronic Signatures. Each electronic signature shall be unique to one individual and shall not be reused by, or reassigned to, anyone else, in accordance with §11.100(a). Before an organization establishes, assigns, certifies, or otherwise sanctions an individual's electronic signature, the organization shall verify the identity of the individual, in accordance with §11.100(b). The organization shall implement the following controls: (a) a formal enrollment process for issuing electronic signature credentials, including verification of the individual's identity through government-issued photo identification or other reliable means; (b) each individual shall be assigned a unique combination of identification code and password (or other authentication components) that cannot be assigned to any other person; (c) electronic signature credentials shall not be transferable, shareable, or usable by any person other than the individual to whom they are assigned; (d) the organization shall certify to the FDA that the electronic signatures it uses are intended to be the legally binding equivalent of traditional handwritten signatures; this certification shall be submitted prior to or at the time of first use of electronic signatures in records submitted to the FDA, in accordance with §11.100(c); (e) the certification shall be submitted in paper form, signed with a traditional handwritten signature, to the FDA Office of Regional Operations; and (f) records ...
E-Signature Components & Controls — §11.200
02/26/2026 GenericEnhancedY
Electronic Signature Components and Controls. Electronic signatures that are not based upon biometrics shall employ at least two distinct identification components, such as an identification code and password, in accordance with §11.200. The following controls shall be implemented based on the signing context: (a) for electronic signatures executed during a single continuous period of controlled system access (a single signing session), the first signing shall require all identification components (e.g., both user ID and password); subsequent signings during the same session may use at least one component (e.g., password only) that is uniquely executable only by the individual, provided the session has not been interrupted or terminated; (b) for electronic signatures executed during periods that are not part of a single continuous session, each signing instance shall require all identification components (e.g., both user ID and password); (c) the system shall be configured to determine when a signing session has ended or been interrupted (e.g., through session timeout, user logout, or system lock), thereby requiring full re-authentication for subsequent signatures; (d) each identification component shall be distinct — the identification code shall uniquely identify the individual, and the password or other component shall be known only to the individual and the system; (e) for biometric-based electronic signatures, the biometric shall be designed to ensure that it cannot b...
Identification Code & Password Controls — §11.300
02/26/2026 GenericEnhancedY
Controls for Identification Codes and Passwords. Persons who use electronic signatures based upon identification codes in combination with passwords shall employ controls to ensure their security and integrity, in accordance with §11.300. The following controls shall be implemented: (a) the uniqueness of each combined identification code and password shall be maintained such that no two individuals have the same combination; (b) identification codes and passwords shall be periodically checked, recalled, or revised at intervals determined by the organization's risk assessment, but not to exceed ninety (90) days for password changes; (c) loss management procedures shall be established to electronically de-authorize lost, stolen, missing, or otherwise potentially compromised tokens, cards, identification codes, or passwords, and to issue temporary or permanent replacements using suitable rigorous controls; (d) transaction safeguards shall be implemented to prevent unauthorized use of identification codes and passwords, including measures to detect and report attempted unauthorized use to the system security unit and organizational management; (e) initial and periodic testing of devices that bear or generate identification code or password information, such as tokens or smart cards, shall be conducted to ensure that they function properly and have not been altered in an unauthorized manner; and (f) passwords shall meet minimum complexity requirements (e.g., minimum length of e...
Part 11 Scope & Applicability Assessment
02/26/2026 GenericEnhancedY
Part 11 Scope and Applicability Assessment. The organization shall conduct and maintain a documented assessment to determine which systems, records, and signatures fall within the scope of 21 CFR Part 11, in accordance with the FDA Guidance for Industry "Scope and Application" (September 2003). The assessment shall evaluate: (a) all computerized systems used to create, modify, maintain, archive, retrieve, or transmit records required by FDA predicate rules (e.g., 21 CFR Parts 210, 211, 820, 606, 111, or other applicable regulations); (b) whether the records maintained by each system are required by a predicate rule or are submitted to the FDA; (c) whether electronic signatures are used in lieu of handwritten signatures to meet predicate rule signature requirements; (d) the risk classification of each system based on the potential impact on product quality, patient safety, and data integrity; and (e) the determination of whether each system operates as a closed system or an open system. For each system determined to be within scope, the organization shall document the applicable predicate rule(s), the types of electronic records maintained, whether electronic signatures are employed, and the risk-based controls applied. This assessment shall be reviewed and updated whenever new systems are introduced, existing systems undergo significant changes, or applicable regulatory requirements change. A system inventory shall be maintained listing all Part 11-applicable systems, thei...
Part 11 Gap Analysis & Remediation Plan
02/26/2026 GenericEnhancedY
Part 11 Gap Analysis and Remediation. The organization shall conduct a documented gap analysis for each system within the scope of 21 CFR Part 11 to identify any deficiencies between the current state of the system and the requirements of the regulation. The gap analysis shall systematically evaluate compliance with each applicable subsection of Part 11, including §11.10(a) through (k), §11.30 (if applicable), §11.50, §11.70, §11.100, §11.200, and §11.300. For each identified gap, the analysis shall document: (a) the specific regulatory requirement that is not met or is only partially met; (b) a description of the current state of the system with respect to that requirement; (c) a risk assessment evaluating the potential impact of the gap on product quality, patient safety, and data integrity; (d) the proposed remediation action, including whether the gap will be addressed through system configuration, procedural controls, technical upgrades, or acceptance of residual risk with documented justification; (e) the responsible party for implementing the remediation; (f) the target completion date; and (g) the verification method to confirm that the remediation has been effective. The gap analysis shall be prioritized based on risk, with critical gaps (those posing a direct risk to data integrity or patient safety) addressed first. Progress against the remediation plan shall be reported to senior management on a quarterly basis. The gap analysis shall be repeated periodically, ...
Part 11 Periodic Compliance Review
02/26/2026 GenericEnhancedY
Periodic Compliance Review. The organization shall establish a periodic review program to ensure ongoing compliance with 21 CFR Part 11 for all systems within scope. The periodic review shall be conducted at defined intervals, not to exceed two (2) years for each system, and shall include: (a) verification that the system remains in a validated state and that all change control activities have been properly executed, documented, and assessed for Part 11 impact; (b) review of the system audit trail to identify any unauthorized changes, anomalous activities, or data integrity concerns; (c) review of user access lists to confirm that all active accounts are authorized and that access privileges are appropriate; (d) review of electronic signature configurations, including signature manifestation display, session management settings, and password policy enforcement; (e) confirmation that system documentation, including SOPs, validation records, and training records, is current and complete; (f) verification that backup and recovery procedures have been tested within the review period; (g) review of any system incidents, deviations, or CAPAs related to Part 11 compliance; (h) assessment of any changes in FDA guidance, predicate rule requirements, or organizational policies that may affect Part 11 compliance; and (i) documentation of all findings, including the overall compliance status of the system, any identified gaps, and required follow-up actions. The periodic review report...
Data Integrity Policy (ALCOA+)
02/26/2026 GenericEnhancedY
Data Integrity Policy. The organization is committed to ensuring the integrity of all data generated, recorded, processed, reported, and retained in connection with regulated activities, in accordance with 21 CFR Part 11 and applicable FDA and international guidance on data integrity (including WHO, MHRA, and PIC/S guidelines). Data integrity is defined in terms of the ALCOA+ principles: all data must be Attributable (traceable to the person who generated it), Legible (readable and permanently recorded), Contemporaneous (recorded at the time the activity was performed), Original (the first recording of the data, or a certified true copy), and Accurate (free from errors, complete, and truthful); with the additional requirements that data must be Complete (including all re-tests, repeat analyses, and any data generated during an investigation), Consistent (recorded in a chronologically logical sequence using approved timestamps), Enduring (recorded on permanent, approved media), and Available (accessible for review and audit throughout the retention period). The organization shall: (a) implement technical controls within Part 11-applicable systems to enforce ALCOA+ principles, including audit trails, access controls, and electronic signatures; (b) establish procedural controls, including SOPs for data entry, review, correction, and reporting; (c) prohibit the use of informal or unofficial records (e.g., scrap paper, personal notebooks, or unapproved spreadsheets) for recordi...
Hybrid System Controls
02/26/2026 GenericEnhancedY
Hybrid System Controls. Where both electronic and paper records coexist for the same regulated process (a "hybrid system"), the organization shall implement controls to ensure the integrity and completeness of the complete record, which comprises both the electronic and paper components. Hybrid system controls shall include: (a) a documented procedure defining which elements of the record are maintained electronically and which are maintained on paper, and the rationale for this approach; (b) clear cross-referencing between electronic and paper components so that the complete record can be readily assembled and reviewed; (c) controls to prevent discrepancies between electronic and paper components, including procedures for reconciliation and verification; (d) the electronic components of the record shall meet all applicable requirements of 21 CFR Part 11, including audit trail, access control, and electronic signature requirements; (e) the paper components shall meet all applicable predicate rule requirements for handwritten signatures, contemporaneous recording, and records retention; (f) a procedure for managing situations where the electronic and paper components conflict, including which component shall be considered the authoritative source; (g) a risk assessment evaluating the vulnerabilities introduced by the hybrid approach, including the risk of incomplete records, transcription errors, and loss of data integrity; and (h) a documented strategy for transitioning fr...
FDA Electronic Signature Certification
02/26/2026 GenericEnhancedY
FDA Electronic Signature Certification Letter. Prior to or at the time of first use of electronic signatures to satisfy a signature requirement established by a predicate rule, the organization shall submit a certification to the FDA, in accordance with §11.100(c), stating that the electronic signatures used within the organization's systems are intended to be the legally binding equivalent of traditional handwritten signatures. The certification letter shall be: (a) submitted in paper form on organizational letterhead; (b) signed with a traditional handwritten signature by an authorized representative of the organization (typically a senior quality or regulatory official); (c) addressed to the Director of the FDA Office of Regional Operations (HFC-100), 12420 Parklawn Drive, Rockville, MD 20857 (or such other address as the FDA may subsequently designate); (d) clearly identifying the organization's name, address, and FDA Establishment Identifier (FEI) number; (e) identifying the specific systems or categories of systems for which electronic signatures will be used; and (f) retained as a controlled record by the organization, along with proof of delivery (e.g., certified mail receipt), for the life of the electronic record systems to which it applies. The certification shall be updated and resubmitted if the organization undergoes a change in legal name, ownership, or if new systems employing electronic signatures are deployed for new predicate rule applications. The Quali...
what
02/22/2026 GenericEnhancedY
Asks for information or identifies something.
when
02/22/2026 GenericEnhancedY
Asks about or refers to a point in time.
where
02/22/2026 GenericEnhancedY
Asks about or refers to a place or location.
why
02/22/2026 GenericEnhancedY
Asks about or explains the reason or cause for something.
how
02/22/2026 GenericEnhancedY
Asks about or describes the manner, method, or degree of something.
because
02/22/2026 GenericEnhancedY
Introduces a reason or cause.
although
02/22/2026 GenericEnhancedY
Introduces a contrasting or conceding clause.
while
02/22/2026 GenericEnhancedY
Indicates something happening during the same time as another action; also introduces contrast.
since
02/22/2026 GenericEnhancedY
Indicates a point in time from which something started; also means because.
unless
02/22/2026 GenericEnhancedY
Introduces an exception or condition that must be met to avoid a stated outcome.
until
02/22/2026 GenericEnhancedY
Indicates the point in time up to which an action continues.
whether
02/22/2026 GenericEnhancedY
Introduces alternatives or indirect questions.
than
02/22/2026 GenericEnhancedY
Used in comparisons between two elements.
from
02/22/2026 GenericEnhancedY
Indicates the starting point, origin, or source of something.
with
02/22/2026 GenericEnhancedY
Indicates accompaniment, association, or the instrument used.
about
02/22/2026 GenericEnhancedY
Concerning a subject or topic; also means approximately.
through
02/22/2026 GenericEnhancedY
Indicates movement from one side to the other, or by means of.
between
02/22/2026 GenericEnhancedY
Indicates a position or relationship involving two or more parties.
after
02/22/2026 GenericEnhancedY
Indicates a time following an event or action.
before
02/22/2026 GenericEnhancedY
Indicates a time preceding an event or action.
during
02/22/2026 GenericEnhancedY
Indicates the time throughout which an event takes place.
below
02/22/2026 GenericEnhancedY
Indicates a position lower than; also refers to something mentioned later in a document.
under
02/22/2026 GenericEnhancedY
Indicates a position beneath, less than, or subject to authority or rules.
against
02/22/2026 GenericEnhancedY
Indicates opposition, contact with, or comparison to something.
among
02/22/2026 GenericEnhancedY
Indicates being part of or surrounded by a group of three or more.
around
02/22/2026 GenericEnhancedY
Indicates surrounding, approximately, or in the vicinity of.
per
02/22/2026 GenericEnhancedY
Indicates for each or according to.
upon
02/22/2026 GenericEnhancedY
A more formal version of on; indicates immediately after.
toward
02/22/2026 GenericEnhancedY
Indicates the direction of movement or progress.
across
02/22/2026 GenericEnhancedY
Indicates from one side to the other or spanning a range.
been
02/22/2026 GenericEnhancedY
Past participle of be; used with has/have/had.
being
02/22/2026 GenericEnhancedY
Present participle of be; also a noun meaning a living creature or existence.
have
02/22/2026 GenericEnhancedY
Indicates possession, experience, obligation, or forms perfect tenses.
having
02/22/2026 GenericEnhancedY
Present participle of have.
does
02/22/2026 GenericEnhancedY
Third person singular present tense of do.
would
02/22/2026 GenericEnhancedY
Expresses conditional actions, polite requests, or past habits.
shall
02/22/2026 GenericEnhancedY
Expresses future intention, obligation, or formal proposals.
should
02/22/2026 GenericEnhancedY
Expresses recommendation, expectation, or obligation.
make
02/22/2026 GenericEnhancedY
To create, produce, cause, or compel.
come
02/22/2026 GenericEnhancedY
To move toward, arrive, or occur.
take
02/22/2026 GenericEnhancedY
To grasp, carry out, accept, or require.
give
02/22/2026 GenericEnhancedY
To hand over, provide, or present.
say
02/22/2026 GenericEnhancedY
To express in words, state, or indicate.
tell
02/22/2026 GenericEnhancedY
To communicate information to someone.
know
02/22/2026 GenericEnhancedY
To be aware of, understand, or recognize.
think
02/22/2026 GenericEnhancedY
To form an opinion, reason, or consider.
see
02/22/2026 GenericEnhancedY
To perceive with the eyes, understand, or refer to.
find
02/22/2026 GenericEnhancedY
To discover, locate, or determine.
want
02/22/2026 GenericEnhancedY
To desire or wish for something.
need
02/22/2026 GenericEnhancedY
To require something essential or necessary.
use
02/22/2026 GenericEnhancedY
To employ or apply something for a purpose.
try
02/22/2026 GenericEnhancedY
To attempt or make an effort to do something.
keep
02/22/2026 GenericEnhancedY
To continue, retain, or maintain in a state.
put
02/22/2026 GenericEnhancedY
To place or set something in a particular position.
set
02/22/2026 GenericEnhancedY
To establish, adjust, or place in a position or arrangement.
show
02/22/2026 GenericEnhancedY
To display, demonstrate, or make visible.
help
02/22/2026 GenericEnhancedY
To assist, support, or make something easier.
work
02/22/2026 GenericEnhancedY
To perform tasks, function, or produce results.
call
02/22/2026 GenericEnhancedY
To make a phone call, name, or summon.
move
02/22/2026 GenericEnhancedY
To change position, transfer, or take action.
change
02/22/2026 GenericEnhancedY
To make or become different; an alteration.
include
02/22/2026 GenericEnhancedY
To contain as part of a whole or add to a group.
provide
02/22/2026 GenericEnhancedY
To supply, furnish, or make available.
create
02/22/2026 GenericEnhancedY
To bring into existence, produce, or design.
update
02/22/2026 GenericEnhancedY
To make current, revise, or bring up to date.
send
02/22/2026 GenericEnhancedY
To dispatch, transmit, or deliver something.
receive
02/22/2026 GenericEnhancedY
To get, accept, or be given something.
follow
02/22/2026 GenericEnhancedY
To come after, comply with, or pursue.
allow
02/22/2026 GenericEnhancedY
To permit, enable, or make possible.
require
02/22/2026 GenericEnhancedY
To need or demand as necessary or essential.
submit
02/22/2026 GenericEnhancedY
To present or hand in for review, consideration, or approval.
review
02/22/2026 GenericEnhancedY
To examine, assess, or evaluate something.
approve
02/22/2026 GenericEnhancedY
To officially agree to, accept, or authorize.
complete
02/22/2026 GenericEnhancedY
To finish or make whole; having all parts.
confirm
02/22/2026 GenericEnhancedY
To verify, validate, or establish the truth of something.
ensure
02/22/2026 GenericEnhancedY
To make certain that something happens or is the case.
manage
02/22/2026 GenericEnhancedY
To be in charge of, direct, handle, or control.
support
02/22/2026 GenericEnhancedY
To assist, uphold, or provide help and resources.
add
02/22/2026 GenericEnhancedY
To join, combine, or include something extra.
remove
02/22/2026 GenericEnhancedY
To take away, delete, or eliminate.
open
02/22/2026 GenericEnhancedY
To make accessible or available; not closed or restricted.
close
02/22/2026 GenericEnhancedY
To shut, end, finalize, or bring to conclusion.
start
02/22/2026 GenericEnhancedY
To begin, initiate, or commence an action or process.
end
02/22/2026 GenericEnhancedY
To bring to a conclusion, finish, or terminate.
save
02/22/2026 GenericEnhancedY
To store, preserve, or rescue from loss.
delete
02/22/2026 GenericEnhancedY
To erase, remove permanently, or destroy.
select
02/22/2026 GenericEnhancedY
To choose, pick, or designate from a group.
enter
02/22/2026 GenericEnhancedY
To input, go into, or begin participating in.
apply
02/22/2026 GenericEnhancedY
To put into operation, be relevant, or submit a request.
define
02/22/2026 GenericEnhancedY
To state the meaning of, establish boundaries, or characterize.
describe
02/22/2026 GenericEnhancedY
To give an account of characteristics, features, or details.
explain
02/22/2026 GenericEnhancedY
To make clear, clarify, or give the reason for something.
consider
02/22/2026 GenericEnhancedY
To think carefully about, take into account, or regard.
determine
02/22/2026 GenericEnhancedY
To ascertain, decide, or establish with certainty.
not
02/22/2026 GenericEnhancedY
Negates a verb, adjective, or other adverb.
also
02/22/2026 GenericEnhancedY
In addition, as well, or too.
very
02/22/2026 GenericEnhancedY
To a high degree; used to emphasize an adjective or adverb.
just
02/22/2026 GenericEnhancedY
Only, merely, exactly, or very recently.
now
02/22/2026 GenericEnhancedY
At the present time or immediately.
then
02/22/2026 GenericEnhancedY
At that time, next in order, or as a consequence.
here
02/22/2026 GenericEnhancedY
In or at this place or position.
there
02/22/2026 GenericEnhancedY
In or at that place; also introduces the existence of something.
still
02/22/2026 GenericEnhancedY
Continuing up to this or that time; even so.
already
02/22/2026 GenericEnhancedY
Before a particular time or earlier than expected.
again
02/22/2026 GenericEnhancedY
Once more, another time, or in addition.
always
02/22/2026 GenericEnhancedY
At all times, on every occasion, or without exception.
never
02/22/2026 GenericEnhancedY
At no time, not ever, or on no occasion.
often
02/22/2026 GenericEnhancedY
Frequently or many times.
only
02/22/2026 GenericEnhancedY
Solely, merely, or exclusively.
even
02/22/2026 GenericEnhancedY
Used for emphasis to indicate something surprising or extreme.
however
02/22/2026 GenericEnhancedY
Nevertheless, on the other hand, or in whatever way.
therefore
02/22/2026 GenericEnhancedY
For that reason, consequently, or as a result.
perhaps
02/22/2026 GenericEnhancedY
Possibly, maybe, or it may be that.
instead
02/22/2026 GenericEnhancedY
As an alternative or substitute.
together
02/22/2026 GenericEnhancedY
With each other, jointly, or combined.
usually
02/22/2026 GenericEnhancedY
Under normal conditions; most of the time.
rather
02/22/2026 GenericEnhancedY
To a certain extent; preferably; used before an alternative.
other
02/22/2026 GenericEnhancedY
Different from the one already mentioned or known.
more
02/22/2026 GenericEnhancedY
Greater in amount, degree, or number.
many
02/22/2026 GenericEnhancedY
A large number of; numerous.
each
02/22/2026 GenericEnhancedY
Every one of two or more considered individually.
every
02/22/2026 GenericEnhancedY
All possible; occurring at specified intervals.
most
02/22/2026 GenericEnhancedY
Greatest in amount, degree, or number; the majority.
first
02/22/2026 GenericEnhancedY
Coming before all others in time, order, or importance.
last
02/22/2026 GenericEnhancedY
Coming after all others; most recent.
next
02/22/2026 GenericEnhancedY
Coming immediately after in time, order, or sequence.
same
02/22/2026 GenericEnhancedY
Identical, not different, unchanged.
different
02/22/2026 GenericEnhancedY
Not alike; distinct in nature, form, or quality.
important
02/22/2026 GenericEnhancedY
Of great significance, value, or consequence.
available
02/22/2026 GenericEnhancedY
Accessible, obtainable, or free for use.
possible
02/22/2026 GenericEnhancedY
Capable of happening or being done.
necessary
02/22/2026 GenericEnhancedY
Required, essential, or needed.
current
02/22/2026 GenericEnhancedY
Belonging to the present time; existing now.
additional
02/22/2026 GenericEnhancedY
Extra, more than what is already present or expected.
specific
02/22/2026 GenericEnhancedY
Clearly defined, precise, or particular.
following
02/22/2026 GenericEnhancedY
Coming after or next in order; the items listed below.
certain
02/22/2026 GenericEnhancedY
Known for sure; specific but not explicitly named.
few
02/22/2026 GenericEnhancedY
A small number of; not many.
several
02/22/2026 GenericEnhancedY
More than two but not very many.
able
02/22/2026 GenericEnhancedY
Having the skill, means, or opportunity to do something.
good
02/22/2026 GenericEnhancedY
Of a high standard, satisfactory, or favorable.
great
02/22/2026 GenericEnhancedY
Of considerable size, extent, or intensity; excellent.
long
02/22/2026 GenericEnhancedY
Of considerable duration or distance.
small
02/22/2026 GenericEnhancedY
Of limited size, extent, or importance.
large
02/22/2026 GenericEnhancedY
Of considerable size, extent, or capacity.
full
02/22/2026 GenericEnhancedY
Complete, containing all that is possible, or entire.
own
02/22/2026 GenericEnhancedY
Belonging to oneself; to possess.
right
02/22/2026 GenericEnhancedY
Correct, appropriate, or in accordance with fact; a moral or legal entitlement.
please
02/22/2026 GenericEnhancedY
Used to add politeness to a request or instruction.
thank
02/22/2026 GenericEnhancedY
To express gratitude or appreciation.
note
02/22/2026 GenericEnhancedY
A written message or remark; to observe or pay attention to.
example
02/22/2026 GenericEnhancedY
A thing characteristic of its kind; an instance serving as illustration.
part
02/22/2026 GenericEnhancedY
A piece, segment, or division of a whole.
way
02/22/2026 GenericEnhancedY
A method, style, direction, or path.
time
02/22/2026 GenericEnhancedY
The indefinite continued progress of existence; a specific point or period.
day
02/22/2026 GenericEnhancedY
A period of 24 hours; the time of light between sunrise and sunset.
year
02/22/2026 GenericEnhancedY
A period of 365 or 366 days; used for dating and tracking.
number
02/22/2026 GenericEnhancedY
A mathematical value; a quantity or amount.
people
02/22/2026 GenericEnhancedY
Human beings collectively; individuals in a group.
place
02/22/2026 GenericEnhancedY
A particular position, area, or location; to put in position.
thing
02/22/2026 GenericEnhancedY
An object, entity, or matter that is not specifically named.
point
02/22/2026 GenericEnhancedY
A specific detail, item, or moment; to indicate direction.
case
02/22/2026 GenericEnhancedY
A particular situation, instance, or set of circumstances.
fact
02/22/2026 GenericEnhancedY
Something known to be true or proven to exist.
group
02/22/2026 GenericEnhancedY
A collection of people or things; to arrange into categories.
end
02/22/2026 GenericEnhancedY
The final part of something; to bring to a conclusion.
problem
02/22/2026 GenericEnhancedY
A matter or situation regarded as unwelcome and needing to be addressed.
result
02/22/2026 GenericEnhancedY
An outcome or consequence; to occur as a consequence.
question
02/22/2026 GenericEnhancedY
A sentence seeking information; to express doubt or inquiry.
information
02/22/2026 GenericEnhancedY
Facts, data, or knowledge provided or learned.
system
02/22/2026 GenericEnhancedY
A set of connected components forming a complex whole; an organized method.
process
02/22/2026 GenericEnhancedY
A series of steps taken to achieve an end; to perform operations on data.
Steven.Kean
07/18/2025 GenericEnhancedY
Who was Steven Kean at Enron?
Enron
07/18/2025 GenericEnhancedY
What was Enron and why is it important?
personally
04/01/2025 GenericEnhancedY
asdfasdfsda
platform
04/01/2025 GenericEnhancedY
asdfsadfsdaf
improved
04/01/2025 GenericEnhancedY
sdafsdafsda
that
09/28/2023 GenericEnhancedY
This would be the definition of the word that 
Warranty
09/28/2023 GenericEnhancedY
What is a warranty, definition here.
PRESSURE
09/20/2023 GenericEnhancedY
definition of pressure
any
09/20/2023 GenericEnhancedY
definition of any
gartner
01/19/2023 GenericEnhancedY
click to visit gartner or definition here  click to visit gartner or definition here  click to visit gartner or definition here  click to visit gartner or definition here  click to visit gartner or definition here  click to visit gartner or definition here  click to visit gartner or definition here  click to visit gartner or definition here 
technologies
01/19/2023 GenericEnhancedY
Definition for technologies  Definition for technologies Definition for technologies Definition for technologies Definition for technologies Definition for technologies Definition for technologies Definition for technologies Definition for technologies
experience
01/19/2023 GenericEnhancedY
Definition for Experience  Definition for Experience  Definition for Experience  Definition for Experience  Definition for Experience  Definition for Experience  Definition for Experience 
Marketing
01/19/2023 GenericEnhancedY
Definition for Marketing  Definition for Marketing  Definition for Marketing  Definition for Marketing  Definition for Marketing  Definition for Marketing  Definition for Marketing  Definition for Marketing  Definition for Marketing  Definition for Marketing  Definition for Marketing  Definition for Marketing  Definition for Marketing  Definition for Marketing  Definition for Marketing  Definition for Marketing 
Strategy
01/19/2023 GenericEnhancedY
Definition for Strategy  Definition for Strategy  Definition for Strategy  Definition for Strategy  Definition for Strategy  Definition for Strategy  Definition for Strategy  Definition for Strategy  Definition for Strategy 
industry
01/19/2023 GenericEnhancedY
Definition for Industry  Definition for Industry  Definition for Industry  Definition for Industry  Definition for Industry 
digital
01/19/2023 GenericEnhancedY
Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital  Definition here for Digital 
sample
01/19/2023 GenericEnhancedY
Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample  Definition here for sample 
organization
01/19/2023 GenericEnhancedY
Definition here for organization  Definition here for organization  Definition here for organization  Definition here for organization  Definition here for organization  Definition here for organization  Definition here for organization  Definition here for organization  Definition here for organization  Definition here for organization  Definition here for organization  Definition here for organization  Definition here for organization  Definition here for organization  Definition here for organization  Definition here for organization  Definition here for organization 
<b>Prototype of New Word Plug in with Smartlinks</b>V11_022326Data Sources
*Word Plug In with SmartLinkNavigation NavigationModule *Word Plug In with SmartLinkNavigation
Form JS: Remove max-width on form elements & Autocomplete Off Date PickersAdvertisers
*<b>Important: Yellow Highlighting (from search) show in Record View<b>Advertisers
<b>IN USE - NEW DESIGN 09/29/23</b>Styles New DesignAudience Advertisers Sponsored Keywords Splash Pages
visual editor / client console / x close editor
Module Designer
Children of this Page
Taxonomy
Dynamic Scripts
Advertising
Site Design & Layout